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Chapter 1 
INTRODUCTION 
Progress in the studT ot arterial disease has undergone considerable 
evoluticn in the last tiftY' Y'ears. Advances in depth ot canprehension ot 
biological processes among all ot the basic medical sciences has preceded and 
conditicned progress in the tield ot arteriosclerosis. Rapid strides in 
anatOll\Y, biochemistry, phy'siology and pharmacology have not onl,y given us 
better understanding ot the ftmctim. ot normal living cells, but have also 
provided both routes and vehicles by which pathological processes might be 
better investigated. As a consequence ot this progression it has become 
increasingl;r evident that arteriosclerosis 18 most likel¥ t.he resultant ot a 
multiplicity ot tactors. These man)" interrelationships require in our opinicn 
a multidisciplin8l"1' approach which is problem rather than procedure oriented. 
Development ot this dissertatim was conditioned by progress made by' 
other investigators as well as by unanswered questions the resolution ot which 
it was telt is vital to the appreciation ot the etiology ot arteriosclerosis. 
Epinephrine induced arteriopathy has gained greater stature as more recent 
studies have demCl.l8trated the interrelationship ot the medial and the advent-
itial lqers ot the arterial wall. Two divergent hypotheses have been 
advanced to explain the etiology ot epinephrine arteriopathy} eIle suggests 
this condition is a CCI'UteQuence ot hemodynamic ettects, while a s8Ccnd 
bypothesis favors a metabolic etiology. The obj act ot this dissertaticn was 
to determine whether the various dru.g interactions which intensity or 
conversel,y ameliorate epinephrine arteriopathy are better explained. on a 
biochemical or a vasopressor basis or by an bypothesis combining both ot 
these factors. 
Stu~ of arteriosclerosis has evolved from ear~ descriptive phases 
defining the fllOrphology and epidezr..101ogy of the lesion to include the most 
sophisticated descriptive and quantitative methodology available. EarlT 
investigaticns emphasized the occurrence of' atheranatou8 or Imsh like" lesions 
in the arterial wall which presumabl1' were responsible for the mortality 
associated with this condition. Observation of' lipid in the human atheroma 
was followed by' Anitschkow' s discovery (1913) that feeding a diet high in 
cholesterol to the rabbit produced lesions which. were similar in some respects 
to those described 1n humans. 
Investigations which followed suggested that generation of the 
atherau. represented a distinct and separate form of arterial pathology 
l.im1ted :in extent to the intimal or innermost laver of the arterial wall. 
Thus, the term atherosclerosis was coined to more clearl;r define and differ-
entiate the atheromatous lesion from other forms of arterial pathology. 
Central to this line of inquiry was the tacit assumption that atherosclerosis 
was pril'naril;r a consequence of deranged lipid metabolism. The simpliCity of 
this concept has had ccnsiderable appeal. 
Discreditaticn of the unitarian theoI1' of atherogenesis resulted 
from more precise quantitation and study' of epidemiological data which has 
disclosed that deranged lipid metabolism is not a sine qua nan of athero-
sclerosis. Ancel (eys (1963) J perhaps the leading proponent of the hyper-
lipemic theory of atherogenesis, h.as recently stated "L'"l the modern era of 
increasing sophistication, single cause theories of the etiology of athero-
sclerosis have given w~ to the general ccncept of a multiplicity of 
influences that promote the disease. The total atherogenic force is viewed 
as the Sllla or resultant of a number of environmental factors operating on the 
basic genetic endOWlllent". 
Similarly', Stamler (1962), lc:ng a respected worker in this field, 
has stated "Atherosclerosis is a disease ()f multifactorial causation. A large 
number of factors, exogenous ar.d endogenous, interact with diet to influence 
the development of the (atherosclerotic) lasien". In supporting this state-
ment Staml.er states that the Frandngham. study in which a large series of 
patients 'Were studied in regard to a number of factors such. as blood lipid 
hypertension, excessive smoking, obesity etc., seems to indicate that v.hen 
two or more of the "defects" were found in any me individual the likelihood 
of atherosclerotic corooary diaease occurring was ccns1derably enhanced. 
Dole at al. (1963) has recentl,y attacked the lipid theory- stating 
"clinicians have overemphasized the importance of plasma lipids. Challges in 
the oomposition of blood plasma are easy to detect but are unreliable as 
measures of vascular disease or as guides to treatment. Arteriosclerosis 
occurs without hyperlipemia and byperlipeLlia without vascular lesions". 
Changes in concept of the etiology of atherosclerosis haTe been 
accompanied by cCllsiderable modificaticn in definition of the nature and 
extent of ~le lesion. 
Ear~ nomenclature characterized atherosclerosis as a degenerative 
ccndition associa.ted with advanced age in which small pustule-like outpoeket-
ings containing stainable lipid farl/led Ql the intimal or innermost ).qar ot 
arteries. In contrast, the term medial sclerosis was applied to changes 
located primar~ in the media. or middle layer of the arterial wall, charac-
terized by degeneration of' the MllSeulariS, fatty degenerat:ton, necrosis and 
finaJ.l.y calcium deposition. 
More recentl3r, the World Health Organization (1958) has defined 
atherosclerosis as Ita variable combination of changes in the intima of 
arteries •••••• consisting of focal accumulation of lipids, complex carbo-
hydrates, blood and blood products, fibrous tissue and calcium deposits, and 
associated with medial changes". 
Although many investigators have characterized arterioaclerosis as 
a disease of advancing age, more recent~ ~IcGill et ale (196.3), Taylor (1962) 
and others have indicated that this cmditicn has its onset in childhood. 
This school of investigators has reported that the earliest lesions are 
believed to be fatty streaks occurring in the intima of child:rea and adole.-
cents. Thus according to McGill (1963), lipid deposition begins in the aorta 
in the first year of life, in the coronaries in the second decade and in the 
cerebral ve.sels in the third deCade. 'lhese fatty streaks are seen gross1,y, 
in fresh or formalin fixed arterial tissue, as yellow opaque necks or streaks 
on the intimal surface. SeDe of the fatty deposits become covered with a cap 
of fibrous connective tissue, forming what is referred. to as the fibrous 
plaque. other fatty streaks are believed to regress without formation of the 
fibrous plaque. According to McGill et ale (1963) it is the fibrous plaque 
which sets the .tage for the cl1nicalll' manifested form of arteriosclerosis, 
as a result of hemorrhage within the plaque and thrcmbosis over the plaque. 
Either of these complications may reduce the size of the lumen, resulting in 
angina, DlTocardial infarction, cerebral infarction or peripheral gangrene. 
According to Ta,ylor (1962), the arteries of adults usualll" contain both fatty 
and fibrous plaques while in the older population fibrous lesims predominate. 
Frogressim of the lesion is associated with widening and thickening of the 
plaque and lU1' be associated with necrosis and degeneratim of the central 
region of the lesion. Further progressicn of the lesiCll includes the accumu-
lation of ntany' small crystals of cholesterol as well as an extension of the 
lesial into the media. With increasing cencentration of lipids within the 
foam cells lnany of these cells disintegrate and an acellular mass of lipid and 
necrotic debris forms. This latter accumulation ot cholesterol and other 
lipids provides the semi-soft or mushy inclusion which characterizes the 
atheroma. Subsequent changes may include ulcerations of the surface of the 
atheroma possibl"v acting as focal point for thrombus fo:r:mation, or hemorrhage 
may occur within the plaque. Ca~cium salts frequently deposit within the 
atherosclerotic plaque, forming fia.kes or plates that may be as large as 1 to 
2 em. in diameter. In some cases the arterial wall may become so severe~ 
calcified that the vessel will shatter whp.Il sectioning is attempted. Medial 
involvement is, according to Taylor, a CClUUllOll consequence of the progressive 
development of intimal atherosclerotic lesions and is frequ.entl¥ found in 
atherosclerotic aneur,rsms. 
Hus (1962) has stated "it is llkelT that if calcific medial 
degeneraticm could be prevented, other factors which enbance prcgressim ot 
most undesiraple atheroarteriosclerot1c changes could be tolerated well by 
most people. It calcific medial degeneration could be prevented , the chain 
of reactims arising therefrom could best be m1n1m1zed or interrupted by 
measures tor keeping the blood. cholesterol level below 180 m.illigrams per 
cent, for preventing unduly increased blood pressure and when indicated tor 
reducing the clotting tend.ency of the blood". In further exposition ot these 
points Bass states that" since lipids invariably aocumulate in the intima of 
maJ'l3" parts of the arterial system in older segments of the population, the 
idea has arisen that some metabolic abnormality enhances the tendency for 
theae substances to accumulate through either a mural mechanism, a change in 
the oompositioo of plasma lipids or an increase in their level. Hasa (1962) 
further states that "there is little doubt that the level and cmposition of 
the blood lipids especial.l;y cholesterol and its esters are factors in the 
development of the disease, especia~ when the total blood cholesterol level 
is long sustained at high levels. But there is no proof that cholesterol or 
lipid levels, customary in man are in thellSelves respCllsible for the disease". 
The :>."'Gasons which lIass (1962), gives to substantiate his position are as 
follows: 1) there 1s no consistent correspc::ndence between the rate of 
progressiCll or severity of the disease and the level of blood cholesterol or 
lipids. 2) The disease ocours eventually in almost everyone irrespeotive of 
the magnitude or the auntim of these levela. .3) Patients with high 
cholesterol levels of 10lg duration mq have less disease than those with 
lower levels of sind J fir duration. 
Hass {1962} has attempted to resolve the disorepancies between 
theoretical oonsiderations and empirioal obserY'ations by formulating a ooncept 
which embodies the au.captibUi ty of the arterial wall to various types of 
damage. For example, all vessels do not undergo medial degeneration and the 
degree of oalcification accomp&.n:ying this damage is not consistent, while in 
other easElS coexistence of these two phenom.ena are cloae1;y related. Thus he 
feels that it is necessary to charaoterize the susceptibility of each part of 
the arterial system to deleterious faotors which may be multiple and not 
necessaril3' idelitical1n all systems or in all people. Sim1lar~, since 
the depooi tion of lipid varies in both hwn.a.ns and animals as well as within 
each species Hass feels there is reason for a.ssuming that the "lipoidosis 
potential" or su.sceptibilitY' to lipid deposition of vessels .f'r(Jll different 
indh"iduals .1ltq V8>ry. Another facet of Hass' theory encompasses the "mesen-
chymal reaction p'otentinl". He indicates that in the course of medial degen-
eration the deteriorative changes may activate mesenchymA in the media, 
adjacent intima, and ad.ventitia. The s1.1bsequent :L'1crease in oollagen and 
activa.tion. of 1mma.ture vascular mesenchyme assists in repair of the media. 
S1milarJ;r, activatim of mesenchyme in the intima may' occur resulting in 
phagocytOSis of the lipid tiill'ld fomatim of foam eells. 
Arteriosclerosis in Animals 
The very widespread occurrence of arteriosolerosis :J.r; its various 
forms in man obviously dictates the need for model l'3ystems in laboratory 
animals which simulate the variot1s sspects of the pathologic processes which 
occur in hUll'Ans. Research a_long these 11.1")e8 h8S taken t\IO principal direc-
tions a) Study of naturally aCCllITine lesions in various species of an~JIla1s 
and b) Induction of arteriosclerosis ill various species by' che.:nical, 
physical, hormonal and dietary processes. 
Study" of naturall,y ocourring lesims has been qui to extensively 
puraued. Species Vtlrying from the aardvark to the wallaby have assiduously 
been dissected end degree of arteriosclerotic involvement has been correlated 
with what is know of the living habits of the particular group_ Fran these 
studies recently reviewed by Lindsay and Cheikoff (1963) certain generaliza-
tions have come forth. It appears that most speCies of mammals studied 
exhibit naturallT occurring arteriosclerotic lesions. This group includes: 
Marsupials such a.s kangaroos. bandicoots, dasyures, wallabies; Primates such 
as lemurs, macaques, baboons, chimpanzees, gorillas; ~odents such as rats, 
mice, squirrels, guinea pigs; Carnivores such as dogs, wolves, foxes, 
eo.rotesJ Felida.~ such as danestic eatsj Lagomorpha such as rabbits, hares, 
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etc. Among bird. naturalJ,y occurring arteriosclerosis has been found in 
chickens .. pigeons, ducks" geese, swan., etc. 
In most species of 1I8-.1S and birds arteriosclerosis seems to be 
initiated by' degeneration of certain components of the vascular wall. If 
lipids appear during the course of the development of the arteriosclerotic 
lesims, this appearance seems to be a secondary phenomenCll (Lindsay &. 
Chaikoff, 1961). The site of lesions varies with species studied. For 
example in rats and cows the lesions involve p~ the intima. In the 
dog and cat both intimal and medial involvement may occur together. According 
to Fox (1911), natural:b" occurring lesions in the rabbit are moat prominent 
in the thoracic aorta where they appear as elevated intimal granulations or 
large flat plaques. Lindsay and Chaitoff {1963}, are of the opinion that the 
naturall¥ occurring lesima in the rabbit are slml1ar to lesions in the human. 
Duff and Ritchie (19,7) have described. three types of lesions in aortas of 
rabbits. Ck>.e COD.s1ated of focal accumulatim of poll'morphonuclear leucocytes 
in the intima and media. A seccmd type involved. medial degeneration, a 
process related to aging, which in advanced o&ses had. converted the aorta to 
a vide calcific tube with irregular fusiform dilatations. The intima vu 
thickened by' fibroblutic proliferation and the elastic laminae and muscularis 
zone of the media were destroyed or disorganized by' var.r1ng num.bers of mono-
nuclear cells that rarel¥ contained Sudan IV staining droplets. The third was 
an unCClllDlOn, naturally' occurring lesion consisting of clumps of mononuclear 
cells immediatell' under the endothelium. According to Linds..., and Chaikoff 
(1961), in moat species of animals, demonstrable lipid 1I8terial cannot be 
found in the earl¥ degenerative lesions and in earq arteriosclerotic plaques. 
Moreover :in moat species :in which lipid material is found in fibrous intimal 
plaques, its presetlceis restricted mainlir to larger and presumabll' older 
mature plaques, usuall3' in the deepest segments adjacent to or in the media. 
These authors state "It must be emphasized that lD'llike the arteriosclerotic 
lasien in man, most later arteriosclerotic plaques in animals do not usuall1' 
ccntain large amounts of lipid". They also state that in a number ol species 
of animals medial disease overshadows intimal fibrosis and thickening. 
Extensive calcification of degenerating elastic tissue and the appearance ot 
increased amounts ot mucoid ground substance suggested to Lindsay and Chaikotr 
(1963), that the medial lesion ma-Y be basicall3' similar to that of the intima. 
Bragdon (1952, 1954) has reported that fatty streakB fOUl'ld in arterial tissue 
ot young children and adolescents are also present in the young rabbit, 
suggesting another s:1.milarity between the human and rabbit forms of the 
arteriosclerotic process. 
Exper1m.entallyr induced lesions ~ animals have been induced by 
dietary- as well as chemical, physical and horMonal means. Anits~ (1933) 
produced "atherosclerosis" in the rabbit by feeding a diet supple1l1ented by 
addition of cholesterol. .Among the advantages of' this procedure is the tact 
that lesions are produced in a relativeq short time and the ease of handling 
the rabbit in the laboratOl"1'. Hartroft and Tbomas (1963) indicate that the 
pathology produced in the rabbit by this Ileans differs from the lesions 
produced in man in that the foam cell is the most praninent companent of the 
lesion, the ucend.1ng aorta is more severe1ir involved than the abdominal, and 
the lesials almost never proceed to ulceration, calcification and thrombosis. 
Another disadvantage of the procedure according to these authors 1s the 
observation that the rabbit is bjr nature a strict vegetarian with a serum 
cholesterol level much lower than that of man, while the levels of cholesterol 
:lD 
associated with lesions in the rabbit are far in excess of those ueualJ,y seen 
in man. Bass et al. (1960)have reported induction of arteriosolerosis in 
rabbits bY' feeding them excessive amounts or irradiated ergosterol. Lesions 
induced were characterized by" bone resorption and by' abnormal deposition of 
calcium salts in various tissues. Calcium appeared first in the inner media 
of the aortic arch. ~~ith time the calcific deposits spread m depth and 
proceeded along the abdaninal aorta and its branches. The principal changes 
which these investigators reported, appeared in the internal elastic membrane 
and the media, while the fibroblastic intimal proliferation reactions and 
vascularized stramal resorption of the media. were the principal manUesta-
tions of repair. 
Tsaltas (1962) has reported induction of arteriosclerosis in the 
rabbit by mjeotion of papain. 'lhase lesions were reported to include the 
development of raised white circumscribed plaques in the arch and descending 
portions of the aorta and its maj or branches. The lesi008 according to 
Tsaltu u8ual.l.y involved the subintimal port.."lms of the media, but some 
extend8li through the entire wall. Elastica was fragmented and the lesions 
contained an abundant deposition of PAS (Periodic Acid Schif'f) positive 
material and calcium. Ccnnective tissue proliferation and oartilagenous and 
osseous metaplasia were also observed. 
Katz and Pick (l961) have produced atherosclerosis in the ohicken 
by' addition of cholesterol to their regular diet. These lesions reportedlJ' 
on rare oocasion mq ulcerate or caloif'y, but according to Hartroft and 
Thomas (1963), differ from human lesicns in that calcification and ulceration 
occurs far less often than in human lesions. 
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The rat has also been employed in the study of arteriosclerotic 
lesions. v.Jissler et ale (19,4) and Fillios et ale (1956) have reported aortic 
lesions follOWing addition of cholesterol, bile salts and thiouracil to a 
semi-S)"llthetic diet. Wexler et ale (1960) produced aortic lesioos in the rat 
by repeated administration of large amounts of ACTH. This group haa also 
reported occurrence of aortic lesions in females which had been repeatedlT 
bred. Cholesterol supplementation and thiouracil added to the normal diet bas 
been reported by' Steiner and Kendall (1946) to produce atheroscleros18 in 
dogs. Cbolesterol feeding in pigems (Lofland 1961) also results in atheroma 
fomatim. 
:§pinephrine Induced Medial Arteriopat& (he of the key findings in 
this area was the report by JUklllcich aDd Oester (19,0) that medial a~al 
sclerosis, origina.lly reported by' Josue (1903) to follow inj ectim of large 
intravenous doses of epinephrine, could be greatly augmented in both severity 
and incidence by concaaitant subcutaneous adm1nistratioo of thyroxine. Subse-
quent stUdies from this same laboratory. rOester (19,9); Friedman, Oester and 
Davis (19,,>. Oester, Davis and Friedman (19,,>; and Roszkowski and Oester 
(1956)] have described several drugs whicb appear to be of protective value 
in the epinephrine-thyroxine reg1Dlen. 
Friedman" Oester and Davia (19,,) reported that although both 
epinephrine and norepinephrine were capable of producing medial sclerosis 
when administered alone or in combination with thyroxine the extent of damage 
produced. by' epinephrine and epinephrine-thyroxine regimen produced not onl;r a 
greater :incidence but also a greater severity of the lesions. Oester, Davis 
and F'riedman (19,,) reported that wben intravenous adm1nistratim of a 
Cholesterol suspen8im was added to the epinephrine-tby'roxine regimen, 
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int1mal sclerosis associated with proli:t'eration and foam cell formation 
resulted, medial damage on the other hand was similar to that observed when 
animals were subjected to only an epinephrine-thy'roxine regimen. Davis, 
Oester and Friedman (19,,) reported that ATP (subcutaneous) was able to 
decrease the severity and incidence of epinephrine-thyroxine induced medial 
damage. }-!ore recently O'Sullivan (1962) has reported that phentolamine 
(Regit1ne) a.dnrlJlistered prophylacticallT <Xl a subacute basis was able to 
reduce both the severity and incidence of medial damage, phen~benzamine 
(Diben~e) under s:i,mjlar conditims appeared relativel1' ineffective. 
Iproniazid (Marsalid) at low doses, was found to significant:q decrease the 
incidence and severity of medial damage produced by injections of epinephrine 
not accompanied by tb)"rOJdne administration. Higher doees of iproniazid <Xl 
the other hand appeared to intensity incidence and severJ.:ty of' these lesions. 
Ccnclusioos drawn from. O'Sullivan's stu.c:\r were that 1) the 
protection afforded by iproniazid was a consequence of its hypotensive action, 
2) the "vell defined and clear cut" protective action of phentolamine was a 
consequence of its hypotensive and adrenergic blocking action, and) the 
rather poor protection afforded by pbenoqbensamina (Dibensyline) was 
ascribed to the lack of marked hypotensi va action apart from the 1nhibiticm 
of the epinephrine induced pressor etfect. O'Sullivan has ascribed the effect 
ot thyroxine in increasing severity ot incidence and severity of epinephrine 
induced medial damage to an increase in resting blood pressure as well as to 
a potentiation of' the pressor response following intravenous epinephrine. 
S1milarl\y, O'Sullivan (1962) has ascribed the protective effect of ATP to the 
hypotensive action of this drug and to a reduction of cardiac rate following 
epinephrine. His statement "that the primary' infiuence in the development 
of epinephrine 1nduced scleroa18 of the rabbit aorta is the increase in intra-
lum:1nal pressure and stroke volume consequent to the administration of 
epinephrine- supports the omtention that the medial sclerotic effectl of 
epinephrine and drugs either augmenting or protecting againlt medial Iclerolil 
are a consequenoe of their cardiovascular and prelsor effects. 
Waters (1954) and Waters and de 5uto-Nagy (1950) as well al Taylor 
(1954) have also supported the ccntenticn that one of the prinoipal factors 
in producticn of atherolclerol18 may be the injury of the arterial wall by 
hypertentian or acute rises in arterial intraluminal presnre. 
A relat10nlhip between medial arteriolc1erolu and atherolc1erOlis 
has been suggested by Conltantinides et al. (1958). They found in a chance 
observaticn that the aortas of scme rabbits that developed accidental renal 
damage while being fed a high cholesterol diet exhibited patchy medial 
necroau associated with an unusualq severe degree of intimal atheroscler08ia 
SUbsequentq Cmstant1n1des et al. subj ected rabbite to a thyraxine-
epinephrine regim.,. similar to that used by Oester at al. (1955). Rabbits 
were given epinephrine 1ntr&Venous~ at a dose of 50/Ig. for a period 
of ten dqs. Durlng the last five da.vs of the treatment period t.hyrox1ne at 
a dose of 1 mg./kg. was administered suboutaneousq.. Atter a four day period 
these animals were given a ~ oholesterol, 5. cottonseed oil diet for three 
weeks and then sacrificed. en autopsy it was found that cholesterol fed 
controls which had not. been nbjected to the epinephrine-th1rox1ne regaen 
did not show &'nT evidence of atherosclerosis, while the incidence ot 
atherosclerosis was 8~ in the epinepbrine-tllTroxine animals. Aortic 
cholesterol cmcentration in the epinephrine-thyroxine pretreated animals 
was six times higher than in cholesterol ted controls. Microsoopio 
III 
exandnation of the aortae disclosed that for the ioost part atherOOlatous 
plaques were found over'4ring areas of medial necrosis. Although the period 
of oholesterol feeding was ml¥ three weeks, the thiclmess of ma.ny' of the 
atherOOlGEl was of a magnitude ObS6l"'7ed only in animals subj ected to at least an 
eight week cholesterol feeding. Constantinides et ale (1960) have cmcluded 
that prior medial injury greatl,v increases the atherogenic response of the 
aortic intima toward hypercholesterolemia and atheroma formation. 
Constantinides and his associates emphasize that these findings are 
of great significance since they describe a mechanism whereqy atherosclerosis 
can develop in the absence of conspicuous or prolonged blood lipid elevation. 
They also help expla:tn t,he pathOletu"sie of some lipid-poor atheromatous 
plaques in humans which have been desoribed as l'funderla1d by foci of medial 
elastio destruotion." 
These findings gain a particular importanoe in that numerous agents 
such as !om (adrenocorticotropic h01'l1.6ne), uneaturated fatty acid deficiency, 
infectioll, etc., have been shown to produce medial necrosis in mammalian 
arteries. Thus Constantinides and his associates view medial injury' as a 
-final cammon pathw~ through which a multitude of stresses might sensitize 
the intima to blood lipids and thus promote atherogenesis even in the presence 
of onlr slight and transitor.y hypercholesterolemia." 
Workers in the field have been aware of the possibility of medial 
damage cmtri'buting to atheroma formation. However, the absence of medial 
damage underl¥1ng intimal atheromas has in many instances tended to negate 
such a conclusion. Constantinidea et ale (1960) feel tha.t one explanation of 
these fuu:1:tngs may be in a greater potential ror medial repair to occur as 
compared with other aortic strata. Another significant factor according to 
1 
this group is that m some of their experimmts they found that in later stage 
medial lesions can break down complete4r, fusing '11th the overl¥ing intimal 
plaques. In this way subatheromatous calcium deposits may become "intra-
atheromatous" • Thus a lesion which began as an uncalcified atheroma resting 
on partl;r necrotic calcified media ma,y end as a calcified atheroma resting on 
an apparently- nonnal media. Perhaps of importance is the observation that 
some of the lesions produced by Ccnstantinides, which were pretiominentl;r 
fibrous and l1pid-poor, are more similar to the human atheromatous lesions 
than the tightly- packed plaques characteristical~ produced by high lipid di 
in the absence of medial injury. 
Submicroscopic !!pect~ The use of electrarunbroscopy as well as 
density gradient centri.f.Ugation procedurev has ccntributed cOIl.siderabl,y to our 
understanding of the relationship of cellular 'ultrastructure and function. 
Siekevitz (19,8) has attempted to draw together some of the information which 
has been made available in recent Tears to formulate a "working ccnceptl! of 
cellular organization which although hypothetical 1n SOUle respects provides a 
profile which assists in the Unification of various isolated concepts of 
cellular ultrastructure. According to Siekevitz one of the structures whose 
functional relationShip to the cell is not too well understood is the endo-
plasmic reticulum which is believed to consist of a system of lumina limited 
by a membrane approximateJ.y- 75 f thick. These lumina take the form. of canals, 
vesicles and cisternae within the cell. '.lhase spa.ees ~ppear tobs :inter-
connected and form a "continuum" which permeates the cytoplasm. of nearl;y all 
cells. '!he endoplasndc reticulum fragments on homogenization forming the so 
called microsomal fraction. According to Siekevitz a common f1nding in 
electron photCD1orographs is a generous concentratioo. of pinocytotiC vesicles 
tiith wM.ch they coalesce on contact. Thus Siekevitz views the pinocytotic 
vesicle as a possible means by which extracellular matter may be tFansported 
to the endoplasiuc reticulum. 
The nucleuo appears to be bounded by two concentric 1ll6mbi"Mes.. em. 
olose examinatiort the :inner ona of the two mermranes curvu back to merge with 
t.he outer membrane at the edges ot the pores which have been described in the 
nucleus. The outer membrane'. origin according to Siekerltz is in the endo-
plasmic reticulum.. In a further exposition of these concepts he postulates 
the occurrence of enzymes such as hexokinase along the wall of the endoplasmic 
retieul.um. 
Rhodin (1962) has :indicated that rough-sur.faced endoplasmic retic-
ulum is extremaJv scaroe in the intestinal smooth muscle but quite abundant 
in vascular lJU8Cle cells. Be turther states "the function of the rough 
surfaoed endoplasmic retioulum and the ribosomes is related to protein 
synthesiS wi thin a cell. In cells wi. th a high rate of protein synthesis these 
cell constituents are quite abmdant." 
Subsequent to the oharacterizaticn ot the mi toohondria as the 
prinoipal site or oxidative phospbOl"",flation ,considerable research effort haa 
been expended to elucidate the morpholog.r of this structure and to relate 
structure to :!'unction.. It is generall¥ accepted that mitochondrial particlea 
are bounded bjr two membranee, the ou.ter ot wh1ch forms the outer ahell, while 
the inner evaginatea taming protrusions into the l1.lltlA!m ca~led crista, 
(Lehnmier 1961 a). 
La~n1nger (1961 b) has indicated that the enzymes of respiration 
and coupled phosphorylat1on are more or less firmly' imbedd0d in or on the 
mitochor.tdrial membranee, and that the cristae are the site of these eo.zymatic 
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activities. His group has fragmtllnted tnitoohondria and found that sizing of 
the particles by differential centrifugat1.on produces particles which appear 
to be relatively constant in regard to content per milligram. of protein 
nitrogen, of cytochrome oxidase, beta hydroxy tutyric dehy-drogenasG, suecin ... 
Gxidase L'td ATLase regardless 01 particle size. theM findings suggest to 
Lehninger that the membranes are made llP of large numbers of recurring 
structural unit. each of which may oontain a complete usembq of respiratory 
carriers present in a fixed ratio. He fllrther indicatea that an individual 
liver mitochcndrion mq contain between fiVE! and ten thousand ot these 
respirntol"1' ..... bUes. 
Although a oomplete apprec1ation of the various functions of 
mitochondria has not been attained, Lebninger i.l1dicates that \-hese particles 
possess three rather cM89icuoua properties nameq 1) eatalTai. of respira-
tion and energy eoupl1ng 2) occurrence of reversible swelling and contrac-
tion lGa.ding to water movements which are geared. to respira.tion and 3) ion 
transport aleo geand. to tho rospirato17 chdn. 
Recent evidence accumulated in a number of laboratories suggests 
that the swelling and contraction of the mitochondria !lIJJ1' be an eJC;Pression of 
reSpiI'4to17 modulation of these particles. This swelling and contraction in 
tum may be a renecticn of mechano-cbem1.cal ohanges of the reapirato17 and 
coupling ens.ymes. analogous to the mechano-ebemioal activities of the 
aetom.yosin oomplex. 
Perhaps ooe of the most useful pharmacological tools available for 
the study Qr m1 tochondrial function is thyroxine. It baa been well known tor 
many years that thyroxine pretreatment ot animals increased respiration of 
tissue slioes fr(D various organs. Hoch and Lipman (19;4) reperted that a 
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Ca1s1atent decrease 1n the p/o ratio could be obta1ned in isolated liver 
ndtochondr:ta tollow1ng tlvToxine addition if the mitochondria were preincubated 
with tb7ro:d.ne prior to addition o£ substrate. .labi and Abelin (195) reportal 
that 11vor llI1tocbondria fran thyrotOJd.c rats exhibited 3n incret;.sed tendency 
to spontaneous 8IfelJ.ing in vitro. Sub.equentli" D.emperer (19$$) found an 
increase in water ccntent in t,hyra:dne treated mitochondria. rap~' ~ al. 
(19,,) reported that ~OJdne added in vitro enhances the nel11ng ot XCl 
suspended normal rat liver IIdtochonclria. 
F rem the pnteed1n, d18C\UJ8ion it 18 apparent that prev1oual¥ held 
opinims :regarding the cause of al"teriosc1erosia are undergo1:rl.g considerable 
revision" In the put" r'JIllT authorities in thi8 tield have held that athero-
8c1eros1l:: is the cons8quenne of a single partieular predispOSing tactor. Hore 
recentl¥ Keys (l963) ad :'ltalllel' (1962). have suggested that atherosolerosis 
is due to a multiplicity of causes. Atheroacleroais has been locked upan 
pr1marilT as a lesion of tb,e intimal layer ot the art.erial wall. As II ems ... 
quellee of the studies of Hus (l96O, 1962), Constantinides (19$8) and others it 
i8 becOBl1ng increalingll' ev-ident that les:i;.(ma of the medial la¥e.r of anen. 
JUT pla¥ an important role in the toraUan of 1nt1mal lesions. Epinephr::lne 
induced. arteriopathT, in the rabbit, appear. to be an excellent model system 
in 1fh1oh 1881ems of the lHd1a 1ItI1' be nudied. (Oester 19S9). Beoause of the 
possible relevance ot epinephrine induced aed14llesions to human athero-
sclerosis 1 t. is iqlo.rtant that the mechanism or aechani$lla by which these 
lesiCllS are produced be 1'l.014e tu.lJ¥ understood. 
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Chapter n 
Statement of Problem 
As a consequence of the increasing appreciation of the role of 
medial dIt.mage as a predisposing factor in arteriosclerosis, cCllfd<~ere.ble 
speculation bas centered around factors whioh may precipitate or cause this 
type of pathology. O'Sullivan (l962) and Lorensen (19$9, 1961 A. it) ~'We 
interpreted medial arter1opatl\Y induced by epinephrine in the rabbit as a 
resultant of the pressor effects of this drug. This poait1en has beal 
chal.1enged by MUch and Loxterman (l964) who ha .... suggested that "ep:1nephrine 
:induces II defect in the biochemical a:r'Oh1teeture of the &l'1;er1a1 wall which 
renders it susceptible to degenerative change. tf 
ExaminatiQl of llte:rature in this field nggested that a better 
appreciatiCll of the importance Cif possible etiological faotors might be gained 
in studies which s1mulated the experimental conditions \D'1der which medial 
arter10patq 18 produced in the rabbit. In this regard it was felt that 
central to the study of possible etiological factors was a studT of the 
pressor effects of epinephrine, norepinephrine, and sclerosis antagonists in 
both the normal and tbyroxlne pretreated rabbit where blood pressure was 
monitored in an unanesthetized sn1mal. Consideration of the varioua drug 
interactions suggested that results of blood pressure detarminat1cns in the 
unanesthetized. rabbit would. give SCB8 indication as to whether results 
prerlousq reported by other investigators might bean. be explained on the 
buis of pressor effects of epinephrine or whether the nature of drug intersc-
ticns:is such as to suggest that observed results might be explained CIl thtlt 
basis of a biochemical theory. In the event that pressor data did not 
eupport either of these hl'Potheses a third poasibil1 t7 might be l1kel,,.. 
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na.mel3', that epinephrine arteriopath;r is a coo.sequence ot a biochEmical detect 
induced in the arterial wall which exerts a permissive actioo. on the induction 
ot les1ms by pureq hydrostatic tOl"Ces. 
Because of the paucitl' of literature data (Il subacute M.ochamical 
effects of epinephrine and tbTroxine in the rabbit aorta it was felt that 
exam1nat:lon or some of the tissue cmstituents would provide infoI'll<.'l.t.:ion 
pertinent to the present. study. Therefore, a subsequent phase of this 
::L:vestigation included stud.;r of subacute eftects of epinephrine <.n various 
parameters such as aortic lactic acid, gqcogen, glucose lactic dehyd.rogenase, 
in animals subjected to the two week tn,rox::t.ne-epinephrine regmen described 
b.Y Oester at ~ (1954, 19$$). 
L1m1tatiar.1 of these b10chemicaletudies suggested that experiments 
in which the eftects of both epinephrine and thyrcx1ne ou carboh;ydrate metab-
olism and protein synthesis in the isolated aorta might provide more mean-
ingi"J.l information. 
The very rapid gl'C'7lth ot radioisotope methodclogy in recent years 
suggl3sted that this discipline could be used to particular advantage to 
elucidate and characterize both normallletabolism in the rabbit aorta as well 
as to provide additional clarification regarding cellular effects of the 
sclerogenic regimen. 
In atDnIJI&ry this problem entailed an evaluation of pressor effects 
of ep1neph."""ine in conjunct1<m with various sclerogenic regimens as well as 
with agents reported to protect against epinephrine induced sclerosis. A 
second phase ot this problem inclllded a survey' of several possible bioehemical 
etfects whicb Ldght contribute evid810e supporting a biochemical basis of 
ep1nephrine induced medial arteriopath1". 
Phase I 
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Chapter III 
Mater1a1a and Methods 
Hew Zealand white rabbits, obtained fran a local source, weighing 
two to tour kilograms were used throughout. Since previous studies by' Oester 
et ale (19,,) tailed to establish a sex dependent relatiemship, animals ot 
both sexes were used in accordance with the procedures al.ready described 
(o.c.). In all acute e:xperlments animals were weighed previous to AnT exper-
imental procedure. In sub-acute experimenta, during wh1ch animals were 
treated tor period. or toumen dq., dail,y record ot body weight was kept and 
dosage adjusted accord1ngll'. Animala were housed in steel cages and ted a 
diet of Purina Rabbit Chow. The quarters were well ventilated and room. 
temperature was kept at a relativell' constant leTel throughout the experi .... 
mental period. 
In acute experim.cts deaigned to determine eftects ot epinephrine 
and ita antagonist8 em blood presaure, the rabbits were weighed, anesthetized 
with chlorotorm, and irsobUized on an an1mal re.8training board. Subsequentl,y 
an incision was made in the inguinal region and the temoral artery bared by' 
careful blunt dissection. A pol,yethylene cannula (PE 90) tilled with heparin 
dissolved in noru.l saline waa inserted. approx1matel,y six inchee into the 
vessel so that the open lumen was located in the Ilidthoracic region ot the 
aorta. Pilot experilllents disclosed that in the weight range used, this 
procedure 1nvariabl,y placed the open end ot the cannula in the mid thoracic 
aorta. Atter insertion the external end ot the cannula was plugged with a 
small. piece of wire and then heat-sealed to provide double protection against 
leakage_ The incisiem site was then closed with cotton sutures, the catheter 
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taped to the inner aspect of the thigh, and the animal was allowed to recover 
from anesthesia. Righting reflex us~ reappeared within fifteen minutes. 
In earl,y experiments blockade of the cannula within 24 hours after 
initial cannulation caused loss of JJtany preparations. Since no detectable 
differences in response to epinephrine were observed in animals prepared the 
previous dq, as compared with animals used two hours after surgery', all 
subsequent blood. pressure experiments were carried out in animals apprax-
imatel,y two hours after cannulation. 
Subsequent to recover,r trom anesthesia animals were placed on the 
animal restraining board and the cannula connected to a blunted 19 gauge 
needle attached to a Statham P23A pressure transducer. A Model 5 Grass 
Polygraph was employed to record blood l'!'essure. Prior to use the Grass 
Po~graph was balanced and calibrated in accordance with manufacturers 
operation manual. 
Intravenous adm1nistratiCll of epinephrine and norepinephrine was 
accomplished by means of a constant infusion pump calibrated to deliver a 
constant volume of 0.6 cc per :3 minutes. Adjustment of total dose to 50~/Jtg. 
was made by varying the concentration of drug. Thus whUe the volume 
remained constant (0.8 m1.) in all cases the epinephrine or norepinephrine was 
administered at a rate of !fIJ't/Kg./:3 minutes. AJ.l intravenous injections were 
made via the marginal ear vein. Both the rou:i;.e fAnu period of administration. 
conforaed to that previously used by Oester (1955) and O'Sullivan (].962). 
PreparatiCl1 of Drugs Unless otherwise specified all drugs were administered 
in a vehicle of sterile-non-pyrogenic saline. 
!f,~i"Phr~,!1 'WU p:t'e~ tr(t.r.1 Or,rstall.i:le :l-epinephrine baa. (Carncagies 
.:..i$1t:l~ed, Lot 13lfYt). stock lolut1orL COrlta.it'led 1 •• /TAl. of saline, eolub41';-
by .nddit.1C11l ot one :a1t.d.ln of' OOllCetrtrated llCl, l'fJagct grade, per twenty' mla. 
ux:1.da.'1.t. TiJe atock 8olut1Gl i.laa stor&;l in & 1're.er at 00, arid t.ha:wod prior 
to t:1nal 1.10 dUut,1m. III seweral aperimdrlta asp Nt .... lee S't.8ndard 
r.;p:1nl99hl·1ne B1t.artr<.&W waa ad.;juateJ. to allcwo conoa,tintiou. PrelI.or l"e:IP« .... 
WSi"$ ldenUeal to tb.oee el.1.;)1ted by the epmepbr1ne 'bue obtained frGn 
e&rnog1ee .Liuu.:ted. 
~~!I ~ (stnthroU, ~ ~, LGI; 1612>1.) va \iHd 
~ St,ook aolu.tJ.c8 'W6Ir8 p~ in awrU.e salin.. ~ll;d l;jMti«l 
of tohy,vGld.no w .. accaapl1all«t by ~ addit.* of o.laN NtiIOH. 'l'he .ol:u~ 
O.2S ... />al, vu no:r.i in fA; f'roeaaeIt .\ 0'7. 
'" Phal'tcilamne ut.b.ane&Ultate u.s.p. CResiUnJ" ~, C1ba, Lot. 1.t.-3a36) 
. 
W8'ft\ dUsolved (10 ... /riJ..) in ~le 8al1ne illl8cl1atel¥ beton u.. 
?henS!l~in. ~. (D~liDJt, SIa1t.h, nine ed i'reuch, 
Lot, Iu-DZ) VM d1iJ8oJ.ved ." • O<lloct.n.\1tm of 2 _./raJ.. 11\ aiierile aline 
pnar t.o \'1M. 
~!!9! (HaN1l14R, v,ynalall Botfillan La Roche, Lot 132) WM diaaol:f8d iD 
et.er'J.a uHno at. a CQ'i.OCt.rat1ol1 \)f S ... /mJ.. The pH was adjut,ecl t.o 
IIPprald.at.el.r $.0 1d.th 11» 1la<il ~wn. pnor to \188. 
~Q81ne 1'~ Soct1wa lal'\ ... obtained trGII liltl"1t..1Gfaal D1oo.b.eII-
1oal8 C.,. (Lot;,64l9). • ...... t..1'a\1f;4 of lDO .... /ml. (in at.eJ."'Jle 
ci1aUJlecl _&tar) •• ~ :t--.iiat,eq PI'iOl" to ue. 
~.9'NP2:.W.~ B1~ (W:1ntbrop CbeI11ula1 Corp. iA IH2.$1UB). The 
~ .. dieeol"f1d at • OU'lCflnvat.icft o£ 300 ... (baee)/1Il. in ateril.e 
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saline prior to use. 
The injectiCll protoool inoluded coo.trol administration ot ep:inephr.in 
or norepinephrine during a three minute period followed by a fifteen ndnute 
period during whioh return toward normal was allowed to ocour unless otherwise 
5Pecified. When ATP, phen~berzamine or phentolamine were administered 
proph7lactioally, the subcutaneous administration of these drugs was performed 
30 minutes before ohallenge with epinephrine. In the case of both phentol-
amine and phen~benzamine a f'ractim of the total dose vas also administered 
intraTenous13 (marginal ear vein) five minutes before the epinephrine 
challenge. Thyrcx:1ne pretreatment eonsisted of subcutaneous inj ection of' 
0.1 mg.!tg. of' th;rroxine daiq in accordance with the procedure employed by 
O'Sullivan. 
The follOWing doses of drugs employed were used l Epinephrine, 
50'O/kg. (as base>; Norepinephrine, ,Ol/kg. (as baseh Thyroxine,O.l _./kg.; 
ATP,200 mgs./q.; Phentolamine (Regit1ne~ 5 mg./kg. s.o. and 5 mg./kg. i.v.s 
Pheno:x;ybenzamine (Dibenzyl1ne), 2 mg./kg. s.c. and 1 rog./kg. i.V"i Iproniazid, 
30 mg./'kg. s.c. 24 brs. before experiment and then 8.0. again ';0 min. before 
epinephrine challenge, five minutes prior to epinephrine challenge an 
additional 15 mg./kg. Was administered intravenousq. 
Phase II 
Drugs employed vere prepared and administered as described :in 
Phase I. At least eight anj mal s were emplo,.fWt per group unless otherwise 
stated. The following determinations on aortic tissue were performed; 
1) Tissue gqcogal using the method of Se1fter at al. (1950). 
2) Tissue lactic acid using the method of Barker and SUlIII8rson (1941). 
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.3) Tissue inorganic phosphorus using the method of Fiske and Subbarow (l929). 
4) Gmcose using the glucose oxidase ll1ethod (Glucostat :reagent~ Worthingtm 
Biochemicals CO%l>., Freehcld, N.J.,). 
(See appendix for descriptim of details of the procedures.) 
N o:naal unanesthetized animal8 received 50~/lCg. of epinephrine and 
were sacrificed by separation of the cemcal vertebrae a.t two, three, four, 
five, six and eight hours follOWing administration of the drug. The chest 
caTitT was opened and the aom rapidq removed. After wuh1ng and removal ot 
the adventitia by stripping. two samples ot aortic tissue were excised and 
weighed on a Mettler balance. (he of the two samples was placed in 10% ltOll 
and beated in boiling water tor a period of )0 minutes in preparatiCll for the 
gl1'cogen anal¥sis. The second piece was placed in cold TeA. and homogenized. 
The latter tissue aupernatant was employed for phosphate and lactic acid 
determinations. 
Phase lIb 
New Zealand rabbits as preriousl¥ described in Phase I were given 
da1q treatment for a two week period as tollows. 
Group 1. Normal ccmtrola (1 cc/kg. i.v. saline). 
2. Th,yroxine controla, 0.1 ag./kg. s.c. 
3. Epinephrine 50'l/kg. of epinephrine (expressed as base) i.v. uin 
Phase I. 
4. Epinephrine SOI/kg. (ct. Phase I) and tb7roxine 0.1 mg./kg. s.c. 
On termination of the two week treatment period the animals were 
sacrificed as in Phase IIa and the aorta d1 vided into three secticns. The 
first two were processed as described in Phase IIa whUe the third section 
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a~plo.red for gluoose, laotic dehydrogenase and protein determinations. Lactio 
d~drogenase was determin&i L~ accorda~ce with the procedure of Sobel et al. 
(1957) described. in detail in the appendix. Protein was determined in accord-
ance with the procedure of Gornill (1948j see appendix). For purposes of 
comparison, samples of thigh ntU.l3ale were also removed and treated as described 
above. 
Phase III 
Rabbits were decapitated and the chest oavity rapidlv' opened. The 
aorta was removed b.1 rapid but oaretul disseotion, care being taken not to 
exert 81lY' aignU'icant traction as the tissue was being removed. The aorta was 
then transferred to a petri dish containing either Krebs-Ringer phosphate or 
Kreba-Ringer bicarbonate 'buffer at rocm. tel.a.perature. During the period of' 
subsequent dissection performed so u to minimize trau.ma, the tissue was 
continuou8~ OJCnellated using either ~ ox;ygen or 9,% ox;ygen - ,% CO2 
mixture. After the bulk of the adventitia and adherent fat was removed the 
aorta waa sliced using a sharp scalpel into twelve sections~ The first six 
successive sactims of the first half were oOB1b1ned with corresponding 
suocessiTe sections of the second porticn so that each sample contained one 
piece from both the high and low thoracic aorta. Pilot experiments indicated 
that reproducibility- from eJq)eriment to experic'l',ent was greater if rOOl'fl 
temperature butfer was used in preference to ioe-cold buffer which tended. to 
produce erratic results. The paired sections were placed into a second d1ah 
which also was axygenated. The samples were then removed to filter paper 
moistened with buffer and ImT visiblT remaining bits of adventitia were 
removed. The tissue was then rapidq weighed on a torsim balance and 
returned to the second petri dish awaiting completion of final cleaning and 
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weighing of the ."t1re series of tissues. Identity of tissues was maintained 
by using a oompartmentalized tissue holder similar to those used in processing 
tissues tor histological fixation. 
Aortic tissue pairs WGl"e then transferred to disposable metabollS1ll 
!'1asks (see appondix) and gassed for a. period of 10 minutes with shaking at 
37°C. A mixture of 9$% ~ - S% (;~ was used in the cas. of Krebs-Ringer 
bioarbonate butfer, while the X:Mbs-Ringer phosphate buffer was gassed with 
loo,C oqgen. 
Subsequentq they were recapped with serum stoppers j small plastic 
beakers containing nuted filter paper wet with 4 N lOB were suspended from 
the stopper. In all experiments radioaotive substrate was added before tissue 
addition to tluk. In drug experimEmts, dru.gs were also added before tissue 
gassing. CGrlcentratians used were as followsl adenosine triphosphate 2 mg/ml 
pbentolandne 0.1 mg/ml and phenOX)"benzamine 0.03 mg/ml. Atter gassing was 
c ..... leted. epinephrine was added to appropriate samples. The tlaaks containing 
tilfsues were :incubated tor varying periods of time in a metabolio shaker at 
80 strokes per minute using a li inob stroke. TaDiperature was maintained at 
37Oc. At conclusion of incubation period, experiments in whiob collection ot 
C~ was deaired, incubation was terminated by the addition of 0.$ 111. of 
4 N 12S<\. The fluks were then shaken tor an additicmal 30 minute period, 
at low speed in an Eberbach shaker to effect complete trapping of CO2• At 
the end or. this period the exterior of the leOH beaker vas washed with 
distilled water, (washings being returned to incubaticm nask) and the serum. cap 
was then placed atop III counting vial containing 0., mI. of Hyaa1ne 10 X 
(Packard Instl"Ullent Co.). Once the serum cap was final¥ sealed in place 
0.4 Ill. of 4 N2K SOu was added to the banging plastic beaker to e.fteet 
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release of the C~ trapped by the KOH. The counting vial wu 8llbsequently 
shaken for an additional period of twenty minutes to effect transfer of CO2 
to the Hya.'1line in the bottom of the vial. When the second shaldng was 
completed. the serum cap was rEtTloved and 10 ml. of Bray's solution (1960; see 
appendix) added.. A plastio cap was then affixed and the sample counted in a 
Packard .3l4X liquid 8cintillat~.or.. counter. The aortic sample remaining in the 
original incubation nuk was t!'ansferred to a sample vial containing 10 ml. 
of a 2,1 chloroform-methanol mixture and shaken for a period of six hours to 
remove moisture and fat. Subsequentl;y, the chloroform-methanol mixture was 
decanted and the procedure repeated. with shald.ng for an additional 2 hours. 
The aortic samples were then allowed to -dry- at room temperature for an 
additional 2 hours and then weighed to detemine dried defatted weight. It 
was originally hoped to determine protein via the method of Gomall; however, 
the addition of acid to release CO2 caused sufficient denaturation to D'.ake use 
ot this procedure tor estimation ot protein nitrogen not feasible. The madium 
cootaining flasks were capped. and stored at 00,. until aubj ected to turther 
ana~ical proces8. 
Procedures involved in stu~ of incorpora"ion ot uniformly labelled 
];ysin. C14 into protein were carried outin a manner sim:1lar to that described. 
above, except that no attempt was made to collect C~ and incubation was 
terminated by removal fr<= medium and freezing of tissue rather than bT 
addition ot acid. 
The tissue was prepared for counting bY' the procedure de8cribed by 
Farrese and Reddy' (196.3). In brief, the aortic sections were added to an ice 
cold hOlllogenizer and hcaogenized in 5.0 mls ot ice cold sallne. During the 
entire period. of hOllOgenizatiCll the tissue grinder was kept in an ice water 
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bath. The tissue debris was th81 removed by centrifugation and the super-
natant used tor preparation ot protein by addhlg 1 ml. of cold 2.,. TeA to a 
1 m1. aliquot of the protein. The resultant precipitate was then iiashed .3 
times with cold 5% TOA, extract~ twice with 5% TCA for 1, minutes at 90°C to 
remove nucleic acids, and washed again with cold TCA. Subsequantl,y the 
residue was washe:d twice with eth;yl acetate to remove lipids. 'Itte latter 
procedUre appeared more dNlirable than the usual chloroform extraction since 
it minimized flotation of protein particles. Finall¥, the protein residue was 
dried in a counting vial" 0., ml. of Byamine lOX added, and the sample 
incubated for 18-20 hours at ,,'~c to effect digestion of the protein. Onder 
these conditions digestion of protein appeared complete and no discernable 
yellowing of the Myamine was evident. Upon CIlllp1etion of the digestion 10 mJ.s. 
of Br~ls solution was ado.ed to the v1al and, the sample counted for a min1m.um 
of ten minutes in a Packard .3l4I liquid 8cintUlatiCll counter. 
In all cases sample counts were adjusted for instrument ef'ficienc,y 
based al counting of a sealed c14 reference standard. Background averaged 
approximateq 80 CPM and sample oounts in each experiment were corrected for 
backgrc~d. Correct1C1l for quenching was performed in accordance with the 
channels ratio method described by Baillie (196.3) and Bush (l963). Briefliy, 
the method involved preparation of several triplicate samples ccmtaining 
var;r1ng cQlcentrations of Hy'udne lOX a strongq quenching substance. Counts 
recorded in the "AU channel 'Were divided by counts recorded in the "Bit channel; 
thtis.ra. t.:Lti, was plotted against countiLg effioiency corrected for instrument 
efficiency_ This linear plot was then used to correct samples for loss of 
CO\'!nts due to qnen.cl:d.ne_ 
'!bus all radioisotope data was converted fran CPM (oounts per 
minute) to DPM (disintegrations per minute). 
Chapter IV 
Reeu.lta 
Szetol1c Blood Pre.sure Effects of Pl"etreatamt by Yarioua druga on the 
pressor response to epinephrine in the unanesthetized rabbit are Ulu.trated 
in figures 1 - 9. Speoific data obtained in these experiments are listed in 
Tablea 1 - 3. Figure 1 illn.trates the pre-infusion oontrol 18ft1 of systol1o 
pressure and peak q.tolio response following epinephrine. Peak systolic 
1eYel attained following norepinephrine is denoted by horisontall7 hatched 
bars. The peak systolio level (Fig. 1) attained follCMing epinephrine, was 
not signitieantll' different from that following norepinephrine, (p}O.OS~ ). 
SimiJar1;y there 11M no .1gniticant difference between net increase :in 878tol1o 
pressure produced 'tf' these two drugs (Fig. 2). '!'he percentage increase in 
s;yatol1o pressure (Fig. 3) fol.lGw1ng norepinephrine .. smaller than that 
fol.l.cad.ng epinfllhrine (p • 0.09). 'l'hil differenoe was in part a reflection 
of the higher centrol q8tol1c level of the norepinephrine group. 
Pretreatment of rabbits for two weeka with thy'roxine produced a 
rise in thepre-1nfuslGl leYel of BT8tolic pressure (Fig. 1) J howenr, both 
the net and percentage inor ... e in S;Y8tolio pressure following epinephrine 
were significantly lower in magnitude than in ullne treated oontrols 
[p values o.o~' and 0.001 reapect1ve].;y (aee F1gs. 1 ... .3 and Tables la and ]h] 
The peak 87etolic level in thia group following epinepbrine was not 81gn1t1-
cantl,y different than that ob.81'T8d 1r.t saUne cantrole (P)O.OS~·). 
Iprcn1uid, at a dose reported l:f' O'Sul11van (1962) to aupant 
epinephrine arteriopathy lowered the peak pressor level attained follOWing 
epinephrine ad1I1nlatratian. The net .,..tolio pressure increase in lprCll1azid 
pretreated. an:laala was not 81gn1tloantlT different trom that observed in 
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saUne pretreated controls (Fig. 2), while the percentage increase vu lower 
(Fig. 3). 
Administration of ATP caused a decrease in control qstolic pressure 
to approxtmateJ,' SS. of that observed in saline pretreated controls (Fig. 1). 
'!he peak systolic leYel following epinephrine was signilicantl¥ lover than 
that obsel"f'ed in controls) hGNever, the net increase did not differ s1gnifi-
cantl3' from that in cmtrola. The percentage increase increase in ..,.sto1:1c 
pressure vas .1gni:tican1;q higher then that observed in cmtrols and 1s in 
part a reflection of lawer ccmtrol levels of ..,..1;0110 pressure in the ATP 
pretreated an1mal.a. Adm:1nistratica of ATl to animal. pretreated for two weeks 
with t~e (Tabla 1) did decrease the control ayatolic pressure, however, 
the peak lVstolic pressure leYel following epinephrine was almost identical to 
that obael"f'ed in thyroxine pretreated controls. Both the net and percentage 
increase in systolic pressure following epinephrine were higher in animal.s 
which were pretreated with both AfP and ~e as compared with anilllala 
receiving thyroxine alone (Table 1). 
According to O'Su11:1van (1962) phentolamine (Regitine) is lIlore 
potent in inh1b1 ting epinephrine arteriopatby than phenoxybensamine 
(D1benS7line) • In the present studies phentolaine pretreatment resulted in 
a lower preinfusim systolic level than did pretreatmmt with phenQlll'bellzamine 
(Fig. 1). Similar13 the peak 8,1stolic level following epinephrine infusion 
was lower in the phentolamine pretreated animals than in the pbenCXXJ'bfmzam1ne 
pretreated animals [p 0.0, (Table la, b)]. The net and percentage increase 
in aynolic pressure response to epinephrine, although higher in the 
phentolwne pretreated group was not statistioalJiy different tran that 
obt&1ned in phema.ybensamine pretreated animals. 
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Diutolic Bloccl Pressure changes followmg pretreatment bl' var10ua drugs and 
following infusions of epinephrine and norepinepbrin.e are silustrated in 
Figs. 4 - 6. Data corresponding to these values 1s l1sted in Table 2a and b. 
Fr1edman et al. (195$a and b) reported that norepinephrine adrrdnistered on a 
subacute basis produced an incidence and severity of medial arteriopatby 
s1gnif1can.tq lower than that produced by' epinephrine administered under 
identical conditions. In the present stud.)" the peak diastolic pressure level 
(Fig. 4) was not s1gniticantl,y different following infusion of these two drug 
S1m1larl,y both the net and percentage increase in diastolio pressure following 
in£usion of these two drugs was quite similar with no statisticalq signifi-
cant d1.tference being observed (Figs. $, 6 and Tables 24, b). Subacute 
thyroxine pretreatment produced an increase in preinfusian level of diastolic 
pressure and also increased the rise :in diastolic pressure £ollow1ng 
epinephrine 1ntuaicm as compared't!ltb saline pretreated controls (Fig. 4). 
Iproniazid at a dose reported 1V O'Sullivan (l962) to augDl81t 
epinephrine arteriopat1\Y lowered the preintuai01l level ot the diastolic 
pressure. However, neither the peak d1a.atolic level attained after epine-
phrine infusion nor the net increase d1.f'£ered significantl,y with that obsened 
in saline treated controls (Figs. 4, S and Tables 2a, b). The percentage 
increase in dill8tolic pressure following epinephrine was higher than that. 
observed in salin·e controls (Fig. 6) and was significant at the S% level 
(Tables 2a, b). 
A'fP pret.reatment decreased the preintusion diastolic pressure more 
than pretreatment with &n)" of' the drugs studied (Fig. 4). The net increase 
with epinephrine was almost identical to that observed in sa11ne contro18. 
The percentage increase in diastolic pressure tollo1d.n& epinephrine exceeded. 
that produced ~ any ot the drugs studied. This observation is in part a 
reflect1C1l ot the rather low pre-infusion diastolic pressure level. A.dm1nis-
traU.Orl. ot A1.P to animals pretreated tor two weeks with thyrmdne signlfi-
cantlv decreased the pre-in!u.sion diastolic level [p 0.001 (Tables 2a, b)] a8 
cOlJlPared with an1mals pretreated with tterraxine alane. The net and. percentag 
increase in diastolic pressure following epinephrine infusion did not however 
8ignif1cant~ differ from that observed in the t}~e ccntrols (Figs. S. 6 
and Tables 2a, b). 
Phantolam1ne decreased the pre-infusion diastolio pressure to a 
greater extent than did phmaq-benzam.1ne (fig. 4). However;l following 
epinephrine intusion the peak diastolic response net increase as well as 
percentage increase in diaatol1c pressure did not differ signiticantJ..y betweEIIl 
the two groupe (!l'ables 2., b). 
Mean Blood Pressure changes in general paralleled effects observed in analTSi 
of systolic and diastolic pressure changes. As in the case of diastolic and 
systolic pressure the peak mean pres8Ure and net increase in mean pressure v 
not s1gni.ficantq different f'oUowing epinephrine or norepinephrine infusions 
(rig. 7 and 8). As in the case of diastolic pressure the percentage increase 
in mean blood. pressure did not cU,fter signii'icant~ when these two drugs were 
compared (Fig. 9 arJ.d Tables la, b). 
Tb;yrox1ne pretreatment increased both the pre-1nru.sion mean blood. 
pressure (;'ig. 7) and the peak mean blood pressure following epinephrine 
inf'uaion as oClll>ared with saline controls, while the net and percentage 
increase in mean blood pressure following epinephrine was not sicniticantll' 
di.fterent from that observed. in saline controls (Figs. 8, 9 and Tables la, b) 
This parallels results obtained in anal¥s18 of diastolic pressure changes. 
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Ipraliazidpretreatment employed a total dose of 7'5 •• /Kg. which 
apprmdmates that reported by Spector et al. (1960) to produce almost total 
il".hib1t1cn or Ilonam:ine oxidase in the rabbit. 'this dose of iproniazid reduced 
pre-infusion mean blood presSt'tre and deel'''e8.sed somewhat the peak mean pressure 
following epinephrine infusion. '!he latter difference was not statistically 
sign1f'icant (Tables 3a, b). Both net and percentage increases in mean blood 
pressure following ep1nap~..rine were not sigT!.ifieantl.y different frem. values 
obtained in sal1ne cmtrole. 
AfP" as in the cue of syst.ollc and diastolic pressure, lowered mean 
arterial blood pressure. '!'he rlse following epinephrine 1ntusiCll achieved a 
peak level lower than that in saline contro18, however, the net increase in 
mean presS'Ul'tt was almost identical to that observed. in oontrols" while the 
percentage increase was s1gn1t1cantll' higher (Figs. 8, 9 and Tables 3a, b). 
Biochemical studies In several pilot experiments the t1m.e course 0 
effects of epinephrine on blood constituents snoh as glucose, lactic acid and 
inorganic phosphate were studied. In general, results were in accordance wi 
data available on other species in that blood glucose and lactic &eM rose in 
compariscn "ith controls. '!'hese data suggested that changes in blood conatit 
uent, plateaued appradaatell' two to three hours folloldng intravenous epine-
phrine ad.min1atraticn. The rabbit aorta contributes Ql:q. about 1 gram to the 
total body mus in a 2 1dl.o rabbit. Thus possible lIletabolic changes in aorti 
tissue vould not be expected to be revealed by a study ot blood constituents. 
Tb,retore tissue analysis of the aorta itself 1mS underta.ken. Pilot experi-
ments vere conducted 1n vh1ch aortic levels of g:qcogen, lactic acid and ph 
phate wer. determined following intravenOltS infusiCll of. epinephrine. Slight 
decreases in aortic phosphate and lactic aoid levels, reaoh1ng minima at 2_ 
hours respectiveq were observed. Theae changes were not howeweJ', statist1-
cal.l¥ 81gnU'1cant. Epinephrine did oause a decrease in both aortic and 
ske13tal muscle g~ogen (Fig. 1, and Table 4). In the aorta, gl,ycogen levels 
decreased. appro:.d.rnatel¥ 40%, as oOMPared wi tIl controls (p 0.0)% (Table 4)]. 
In skeletal muecle obta:1n.ed frOU1 the inner aspect of the thigh, ill-cogan fell 
approx1matel¥ 66% as compared with c<I'ltrols (p 0.00]$). Th18 depletion was 
maximal at four hOl.U'8 atter epinephrine adaini.tratian. 
Since ~. has .. known glycogen. depleting effect it was felt 
that determination of the effect of the sclerogenic regimen with appropriate 
controls might suggest further routes of exploration. Thus four groups of 
eight an1mals each were treated dail3 for fourteen da;ya as tollOW's. 
Group 1. Saline controls 
2. 'lbI'roxine 0.1 JDg./kg. 8.C. 
). Epinephrme sor/kg. i.v. 
4. Epinephrine 50t/kg. i.v. + 'lb,yroxine 0.1 mg./kg. s.o. 
The results obtained are illustrated :1n Fig8. 10 - 14. 
Subaoute administration of thyrQIC1ue or ep:S.nepb:r1ne alone did not 
aign1!'1cantq decrease aonic gl¥cogenj however when ad1A1n1atration of both 
dru&8 was combined. a signifioantl¥ lower level of aortic glyoogen wu observed. 
(Fig. 10). a:qcogen in skeletal muscle was somewhat higher in the tlwrOldne 
treated. rabbits and lower in th¥'roxine + epinephrine t.reated animals as 
compared with controls. Theae difference. were not statisticall.Y a1&nUicant 
(Table S). 
Aortic iltlCose levels (Fig. 11) were elevated in rabbits which 
received either epinephrine or epinephrine plns tJwrox1ne (P .. 0.01$). 
An:hruals receiving t.l\Yroxine alone had aortic g::ucose l.evels not sign1ficantq 
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dii'f'enmt .t'rca those fcrund in saline treated cmtrola. Although ekeletal 
muacJ.e glacoae wu elevated in all three experimental groups thia 1ncreue was 
signifioant .ll' in the group recei'rlng epinephr1ne alone (Table 6). 
Aortic lactio acid, in the tby"roxine and epinephrine treated groups 
(Fig. 12), was similar 1n magnitude to that found in saline oontrols. The 
eleva tim in aortic lactio acid seen in the epinephrine plus tl",raxine treated 
group wu not statisticallT signifi.aant (Table 7). No signiticant changes in 
ebletallulscle lactic acid were observed in anT of the e:xper:im.ental groups. 
Similarlv no significant changes in lactic d~enaae levels were ohesrvee! 
either in aorta or skeleta.l muscle (Table 8). Aortic pb08';.b.ate was lower in 
tll1roxine and thyroxine plas epinephrine groups, while in animals receiving 
epinephrine alo.ne levels were almost identical to those oOseNed in aaline 
oontrola (Table 9). 
Ph .. e In 
At thie phue of the investigat.iOllB it was telt that u.e of' 
isotopical.ly labelled auostratea; might provide evidenoe ot a DlOre direct 
nature as to the effects of both thTroxine and epinephrine on aortio tie.ue. 
A number of pilot experiments were oonduoted in an effort to aoh1sve ntis-
factory consistency of resu.lts. Data obtained on clb.~ producticn and 
standard error were oCl'l81atent with those reported b.r Muloahy and Winegrad 
(l963). Kinetic stUdies were oonducted en both normal and tliO week thyroxine 
pretreated animals. The •• data are illutrat.ed. in Fig •• 16 and 17. In all 
radio1aotope e;xperiaents counts per Jid.:nute were corrected to disintegration. 
per Ddnute (DPM) by ue ot the cllaunels ratio method and ext.r&.polated from a 
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In aortic samples incubat.ed for a period of tvo hours in Krebs-
Ringer phoaphat.e butfer (D!) epintl.Phrine appeared t.o :increase c1402 proc1uc-
tiGll by apprax1Jaatel,y thirty p.:reent (Figs. 18, 21 and Table 10). When either 
ATP or phentol..ud.ne .ere added to the aortic s&1llPlea OCl'lta1n:lng epinephrine a 
decrease in C~ below control le9'el8 vas noted. lihCl phanax;ybanzlJldne wu 
added hOlfenr, c14~ productiCID did not dUfer sipit1cantll' tr_ control 
Talu.es. 
If _ the other hand aortic samples were incubated in a Xrebs-R1n&er 
bicarb ... te buffer CGDtaining O.Sj(MIlIl.. of unlabelled. glucose, a lIUoh ure 
s1gn1t1cant ri,e in c~ productiCl'l vu noted in the epinephr1D.e tlJeated 
,~ta (Figs. 19, 22 and Table ll). Norepinephrine under equivalent cCIlditiCl'ls 
tailed to produce a significant increa,. in c~~ productiGD (Table 13). AfP, 
although antagaoizing the st1llu1ant etfect. of epinephrine, did not appear to 
caUie u great an inhibition as either phentolud.ne or phmoq-benzud.ne. When 
aortic ,ample, vere incubated vith glucose 1-014 some increase vas obeel"Yed 
ewer that with the label in the 6 posit1al (Figs. 19 and 22). Epinephrine did 
not hOll ... er appear to cause as great an etfect on c~ productiCll with the 
label in the 11 position as compared nth C-6 labelled glueo ... 
When aortic samples from an1mal8 pretreated s.c. with 0.1 1lI./ke. of 
tbJroxlne tor two weeks, were incubatacl :In ICRB bu.tter u described above an 
almost two fold incr .... in c~ prot:lucticn vas noted (Figs. 20, 23 and. 
Table 12). Additim of epinephrine caused an additicnal two-fold :incre .. e :in 
c~ producticn. this st1malation of c~ prOductiOll wu not blocked by A'tP, 
but wu inhibited by both phmtolamine and phClOll:1'benzam1ne the t01'll81" prod-
ucing a greater 1nhibi tion. Incubation of aortic tissue tram thyroxine 
pretreated an1mal.ll with glucoae labelled in the III poeiticm resulted in an 
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almost sixfold increase in cl40z produotim as compared with CI1.lI' about a two 
fold increase observed. in normal animal. (Figs. 20, 23). Addition of epine-
phrine to aortic samples from thyroid an1m.als incubated with glucose 1-014 
evoked little incr ... e in c~ productim (Figs. 20 and 23). Neither A'I'P nor 
phenQ1C'3"benzamine appeared to signUicantl1' affect c~ production from glucos 
1...c14 while some inhibition was noted in samples treated with phentolaDdne. 
Thus in all. three series of experLaents epinephrine produced a 
significant :!nerease in c14~ produetiCll vb_ eompared wi til control samples 
alao incubated with glucose 6-014• Bot,h phento1aaine and phenox;ybenzamine 
were found to inhibit c~ productiCll, phentolamine being the more active of 
the two drugs 1n this respect. AfT! appeare4 to ettect some inhibition or the 
stimulant etfeat or epinephrine in the 'reba-Ringer phosphate (m) and ltreb.-
Ringer bicarbonate (DB) butf81's but onll' weakl¥ so in the DB + ,lue ... 
seri... Whm.AfP was added to aortic aamplea from. TbTrox1ne pretreated 
an1.mala little or no effect was noted. 
Incubation of aortio tisne with ll's1ne U.t. 014 resulted 1n 
incorporatim of this amino acid into prote1n. Epinephrine inhibited thia 
incorporation (r1&se 24, 2S). For aumple at me hour the rate of incorpora-
tion of labelled q8111e into protein in tissUe treated with epinephrine waa 
CIrlll' about a third of that observed in untreated oontrola (Fig. 24 and 
Table 14). Aortic ti88ue from animala pretreated with th.yraxjne for two weeb 
exhibited an incorporatim rate less than forty percent of that observed in 
normal. controla. Aa in the case of the noral animals, thl'roid pretreated 
aortas appeared senaitive to the i1Ihibitol')" effect of epinephrine on l¥sine 
incorporati<m into protein. ATP appeared to antagonise this 1nhibitioo, 
bringing the incorporation rate up to almost the control level in the 'tbyroid 
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pretreated group. Neither phentolamine nor phenoqbenzamine appeared to 
effect any significant reversal of epinephrine inhibi t10n of lTsine 
incorporation into protein (Fig. 2> and Table 14). 
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Acute Itt.eta Of lpiD8phr1ne (I) or IoreplDf1J)lu1.- <a> on syatolle Bl.OO4 
Pre88'Ul'e in the ~thetiHd Ia~i t PoUow1na Pretrat.nt by Varloue Druaa. 
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'1'be :tol.l.cN1ns doe_ were ..,lOJ8d: (I) epinephrine 50 /kg., <a) norep1ne-
pbr1M 50 Iq.j (t) tbyrox1De 0.1 ma./q.714 4qa a.o.; (I) lpron1u14 3Onta~ 
a.c. 2"- bra. before and apia 30 iii_tee before ep1Depbr1ne toll.oweCl by 
15 q./ka. i.v_J (A.,) adeDoeSM tripllo8phate 200 .".7q. a.o.; (ft) 
fheDtol_- BeptiM 5 mg./kg. a.c ... 5 q./ka.1.v.J (D) plleD~ne 
(D1'tJerlJ)"l:LDe) 2 q./q. 1.91. U4 1 q./ka. 1.v. All sllbfttaneou <a.c.) 
iDJeoUons ve.re _i.iatend 30 II1JNtetJ ,rior to eplnephr1De ohal.lenae unless 
othe1'V1M .taw. All latl'llYeDOWJ (1.v.) 4rus pretrea1;.lleD1f va.a "'1ntaterel 
, IliDUtee betOft ep1lMr.Phr1ae chaUeaae. I1pt oi.ls .... per iJ'OUP uoept 
aorep1Mphr1De srouP eoaalaW of HftB 8121_1. ad. tb;trox1M 81"OUP caulateet 
of JdJ:Ie ul.1 a. "Ccmt1'Ol" reren to ayatoUc blood preuure nbaequeJlt to 
drug pretnBtaent but pnor to B or B. 
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Acute Effects of Epinephrine E or ~orepinephrlne HE on Diastolic B 
Pressure in the Unanesthetized Rabbit Following Pretreatment by Various Drugs. 
Fig. 4 
. 
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The follOWing doses 'Were employed: (E) epinephrine 50 /kg.: (NE) norepine-
phrine 50 /kg.; (T) thyroxine 0.1 mg./kg./14 days s. c.; (I) iproniazid 
30 mg./kg. s.c. 24 hrs. befo~ and again 30 minutes before epinephrine 
followed by l5mg./kg. i.v.; (ATP) adenosine triphosphate 200 mg./kg. s.c.; 
(It) phentolamine (.Regitine) 5 mg./kg. s.c. and 5 mg./kg. i.v.; (D) phenoxy-
benzamine (Dibenzyline) 2 mg./kg. i.v. and 1 mg./kg. 1.v. All Subcutaneous 
(s.c.) injections were administered 30 minutes ~rior to epinephrine challenge 
unless otherwise stated. All intravenous (i.v.) drug pretreatment was 
administered 5 minutes betore epinephrine challenge. Eight animals used 
per group except norepinephrine group consisted of' seven animals and thyroxine 
group consisted of nine animal s. "Control It refers to diastolic blood 
pressure follOWing drug pretreatment but prior to E or HE infusion. 
Acute Bf'tecta Of Epinephriae (I) or hrep1nephr1ne (D) on Mean Blood prea.ure 
in the lJDaDea~izedBabb1t PoUowtq pretreatment b1' VariOUS Drugs. 
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!he tolJ.ovina 4os .. were eaploye4l (.) 9iaephrine 50 /kg.; (_) DO:repineph-
r1De 50 /kg.; (tt) tb,;yrax1De 0.1 q./kg_/14 .sa,. a.c., (I):i,Pl'OIl1aZid 30 mg.l .. 
a .c. 24 hl'II. 'betON aDd ap.1Jl 30 llirmtea before epi~ toU0ve4 by 
15 mg./q.1.v.J (A'1'.f) a4en0aiM tn,holIpbate 200 mg./kg.a.c.; (a) pbentolam.i 
(Ieg1tine) 5 "./"a.a.c. ud 'mg./kg.l.v.; (D) p~u1ne (D1benzy11ne) 
2 mg./ke- i.v. u4 1 mg./ka.i.v, All aubcutaneous (a.o.) inject10as vere 
"2niatered. 30 1I1mttea prior to ep1aeplu1.ne cbaUeuae UDl.eaa otherwiae 
stated.. AU 1Dtra'VOO\lS (i.v.) 4ru& pretreat1DeD:t vaa adain1ate:rect 5 minutes 
before ep1nepU1Dl elIa]]_.-. Eight aDJ_l. lIH4 per group except 
norep1JlepUiae ~ CODalsted. of seven ard.ul.aJt)qros1ne group COD8iate4 of 
Dine ani_] s. CoDtl'Ol· retera to IUfdl blood pressure sub.equent to drug 
pretreatmellt bUt prior to lora. 
11"t~ of SulIuute A4ra1n1atratloa of t'tqrOX1M (T) &DI. Bp1nephr1De (-) on 
Yari01Ul tissue Cotaetltuenta 1n the Iabb1t. 
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Am_la were tnate! as follows: (e) COIltrola 1 al./kg. aal1ne l.v.; (Be) 
ep1rlepbr1ae 50 /kg. i.v.; (m) ttqrox1ne 0.1 rag./kg. a.c.J (Bt-!') epiaphria 
an« tb;Jrox1De as aboYe. Period of 4rug administration _s 2 weeks. 
Effects or Subacute Administration of '1'hyrox1ne (,) and lpinephl"1ne (E) on 
Varioua T1uue Conat1tueate in the R&bl:d.~. 
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Acute Itt.eta of Jl.p:lI.phrine on Aorta Ol1oogaD. 
80 Fig. 15 
..,so 
.4.0 
,30 
20 
10 
o 1 2 
ACUTE EFFECT ON EPI 
3 -4 !) 6 7 8 Hr.. an.l" !)Or/Kg. Epi. 
Babb1 t.a were tasted. 24 bra. prior to adm1 ai strat1cra of 50 Ikg. .,1aephrine 
1lltraftACNSq. 
1:6 
.-i" ' 
Effect of Incuba.tion Time en In Vitro clho2 Production Fran Glucose-6-C14 
by Rabbit Aorta 
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Incubation medium oonsisted of IRP - Krebs-Ringer Phosphate Burrer. Each 
tissue sauple was inoubated with 0.5 microcurie. of glucose-6-C14• Samples 
were shaken in a .etabol1o shaker at 80 strokes/minute. Te.mperature 3700. 
Incubation of aortic samples was stopped at 1, 2 and 3 hours by add1ticn of 
liN sulfurl.o acid. ~e pretreated animals received 0.1 mg./kg. of this 
drug aubcutaneousl¥ for 14 day'S. (Epi) epinephrine o.5r/ml. of medium added 
at beginning of incubation. 
In Vitro IJlcnibatlon of Jtabb1t 40rta 
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JtS.qer lU.ca:rboBtlte butters. D.rq concutraUou UK. (a) eplMphrine 
0.5 /ti., (AlP) a4eaoelne tripla08phate 2 mg./ml., (a) pherl'tolam1ue 
(lept1Ae) 0.1 JI&-/"".' (D) p~D8 (Dibenzyllne) 0.03 al./al., 
0.5 m1croour1. of c-labelled &lupe vas ad4e4 to each U88U.e eupl.e. 
Iac\1baUOIl time .. 2 boura at 3i'C., SO atrokes per JII1aute. 'l!b;rl'ax1ne 
pntreat.llent 0.1 ras./kg. subcutaDloUBl,y tor 14 4&78. 
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Ineubaticn medium cCI1sisted of ImP - Krebs-Ringer PhOBphate or DB - Kreb .... 
Ringer Bioa.rbcnate butters. Drug concentrations used: (E) ep:!nephrlne 0.'5l1 
(UP) adenosine triphosphate 2 mg./ml.; (R) phentolamine [RegitineJ 0 .. 1 mg./! 
(D) phen.oqbenzamine (D1benzyl.1aeJ 0.0) ml../ml.J o.s m1crOourie of ella. 
labelled. glucose wu added to each tissue sample. Inoubat1C11 t1lA.., wu 2 hours 
at 3100., 80 strokes per mnu'M_ Thyroxine pretreatmmt 0.1 mg./kg. 
subcutaneouall' fw 14 dqs. 
In Vitro Incor,poration of Uniforml.y Labelled (u.l.) Lysine cl4 into Protein 
by Aortic Tissue. 
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Incubation medium consisted of DB - KJ:oebs-R1nger Bicarbonate bu:t1er. Each 
tissue sample was incubated With 0.5 microcurie of u.l .. lysine cL4 • Drug 
concentrations used: (a) epinephrine 0.5 /ml..; (ATP) adenOSine triphosphate 
2 mg./ml..; (a) phentolamine (Rag:ltine) 0.1 mg./ml..; (D) pheno;vbenzamine 
(D:lbenzyline) 0.03 mg./ml..; Incubation time was 2 hours at 3t'C., 80 strokes 
per minute. Thyroxine pretreatment 0.1 mg./kg. subcutaneously tor 14 days. 
Table 1a 
Effect or Iatruencnm In.t'Ul_ or lpinepb:r1ne (!PI) ar lorepmepbrine (IE) Fol.l.ow1Da 
Pretreatmct br Var10u U:raga GIl Syatol1e BloocI Preeave 1n the Unae8theUsed Babbl~ 
.- -t-' - .-.. ~- -- '--y-""-' ---···'T··-·"~>< ----.r .. _ ...- -.' "~-"r- ··---···-T"-'-' »-----r-------... _-. 
Oroup! Pret.reetaet ' No. or I CGntrol. L1mtl 1 PreaElClr I Pre880X" ; Net Incraaae ~ • InOraM 
I !.J:p8. i ~B8. ! Drug I aespcmset Illl\elf&. ' 
j ., -.~ i I j -----.-
-11' ~ .. ~-. -- -: 8- -1-·~~~- r~~: r'li7~ : ---~~.-- n.62---
-2-t·Salm.---- '_'._-, r-- -8·~---·!-- .. ----;;--- t -.;- r~ --l--;';' -~!---~---- -'-. '" 
i 1 IIl/Ii s.c. I : ~S • .3 SO'5/Kg. j ~6 1 tlk4 ! ~1.36 
'--'- r --- .-.. - -- -' -----!---- .. -_. _:' __ ~ ____ C<' __ '_ - - ""._ •• - .. _··r· .. ···-_···---r-- -.. -----.- ....... ",.--.-.- ... -.. ~--. --'" 
J t~.· I,! ~ 1P.1 I 121 1 q~ ! 27 0.1 mc/Kg (s.c.) i ! 1.4.6 SO{/Kg. I -2.8 I ~.3 ; *2.12 
- - - .• , ~. --- -.- .. _. - t· .- - -- .. --+.---- ._-- .. - --.. --.- .. - ·4- -"'-'''-'''- -t--~----~--.. ----"t··-··----· " --. _ .... _ ...
: I ~~~:;:~~~) 1-' : l-·~~~·+~~~ i-]~+-·g~l···-l" ~:.8 
r I I *S.2 ; r;o~l". i alD.. I to.sa I 17.)8 
-Tl i;!..;t!{./a~~)_.j-. -7' +. -96-'--1- BPi-! 14S' - :-ss- -'-r-si' --
! 30 lIflIr.g (a. c.) t ; ".0 I r;oJ7r~. .t.S.8. tI6.S *'S.l 
-- -+ _~.~ .. ___ ._ .. _ .. ___ . __ l.. _ _ ._".-t.... .-....... __ ........ - -~j ----- --- .- '- i" -. -.- .~- .... - -- -- ..... ,,- --~.-
1 f Pbentolmdne(aegitJna) . 8 I 6, ! Bpi , 72 i 16 27 
\ S ag/rg (a.e.)+> JI8/l, J..V. I t.S.12 ! 5Or7Kc. t 13.7 f ~.S1 1).) 
_._ .... ! _ ...... -- .--' '''' ----- .. ---- .. t ... -'.-- .- t,··_· .. _----_··,·--_·t---"- .. ,,- ._- ·-t-· .. · .... ··----f'· ...... _._ .... _...... .... .-- ..... 
8 ;Ph~ .. 8 II 15 l JP.i ! 88 i 13 11 
: (MhensyUne) \ .. , t).53: SOt/Kr. ! !.6.S4 i !2.16 !.4.lJ 
!. 2 mg/re (a.e.)fl aa/Ic 1. V'.! _ . _'. . ; _ _.'_". _I.. ._ _ _.._ ._ ,. ._. 
-~ *---ri~.-.. -adldi18tftWl daili' tor ;,: p8rlAd'Qr"-2" ~ prior to apef'laenta. 
All oth.- 8U.bcutJmeoua (s.,c.) adJdn1stra:t1cms were made 30 Jllinutes prior to fo1)1nepbr.tne &dJdn1atraUon. 
Iprcniaid (a.c.) was in addition adm1n1stered 24 Ian. p:rl~_ to g1"Gt\p 16 eJlpSr1menta. -
IntraYCt0U8 (1 .. "1.) drug pretreatment vas admsnUtered S IIdmttu prior \0 epkaphrine infulld.cna. 
\J1. 
o 
Stat1atical Anaqaie of Systol1c 131004 Prea811l'8 
Chan, .. in Table 1 a 
-~."" ... , ----- .-~. t .. ~- ~ .. 
I 
1 va 2 1l.S. I u.s. 0.0$ 
-","~",-- -"-- --_ .. -+-- ,-, .. ",,-,--, "'-"----"'~'-'i-' "" -- "" - --'"' "'- .. ---- "t ,",~." -. -.. "---.,, .. --.- ,,,,~--------- ,.,---_ .. -
1 va 3 u.s. 0.0$ 
I 
'. _._-'-,,,.---'-,,_.,, ,,-- +-,.,--- ---. --",," 
1 Y8 4 ~O.OOl ; X .5. ~'_''''''.~''-''' ••• ' • __ .~ *> .... ,.,_<_ .. ' .•• _.""'" ._~.~ - ...... ~"l .... <_._~. " .- ...... _, ... -_~"_ "-'. o.o.s 
1 .,.,! o.os 
,,-- '''-'~''''--- '--.. ·l·-----,' ",-- -'.",-,,, 
1 V8 7; ~O.OOl 
N.S. , Ii.S. 
--, " \-".- '" - " ,,---,." "-"-'-"-' ,,----,._,--,"---
( 0.001 
(0.001 
, 0.01 
.".i------~-,--,-------,.""-.-. 
B.S. 
Table 2a 
Effec'\ of IntraftnOUB In1\ud.on of Epinephr1ae (BPI) or lorep1n~"le (ME) 1011(1111,,"'. 
Pretreatment by Va..""'ious nz.,lg8 an Diastolic B100d Pr .. 8lJN :in the tmaesthetued Rabbit 
......... ,,,._- ,-,-- .... _, ._---"'-','- - .. - ......... ". __ ._ .. _ .. ,_.- ,,---,-... ~ -;-'-_.- ... ,.,-'------.-- r' ,--,. "~'_H --.' -",-' -_._, .... -
Grcap Pretreatment, : No. of ! Centro! LeYel: Preasor: Preseor I ret Increase ( ,; Increase 
,E:<:pa. ' JIlit.Hg. ' Drug i Responee! E.Hg. . 
: mm.Hg. 1 
..... +, . __ .'" .~_ ,~, .. ~ ~.~ ,~ .. .; __ ,_ .. A. __ ~_ M_ ·~-l,- ~., ." ---~~-~."." .. , 
82 'Bpi I 111 ,38 46 
t.h.BS ! SOJ/ptg. i 112.3. t7.5 t.B.2 
_, ~~. ~ __ ~ ". ~_ i ....... __ '-"' _,,_ "",~,_~ _._ n.~' ,,,,.' ,"_~~_~ "",- to, ~ ,..-'.¥ v~ ~ - ",.- -.. ,~ ~ ---.~- ... __ ,_~ -.- ~-'~'~.~- .. _ ..... , .~-
8 
, 
2 i Saline 9 8.k n 126 
! 1 aJ/Kg a.c. 1 U-53; SO(ftg. , :4.2 
-- -_., •..• ,-, -,- ,-_ .. ,-, -_ ... _- .,,.-:._, ----;-'--_. - ~.'---'- -,i---"'- ' •... ,-
3 : ~.* '9 i J..a2 ! Bpi 158 l;r . S1 
: 0.1 arft.& Ca.c.) 1 . ~l.3 ; SO 0/'18. :'2.;6 l t.).,LJ i ~.2S 
--.. -:---, ._-- "-"' ... ,'-, .-. ". __ .,--'" ".,,' .. _,.,. -_._ .. "~._,-_., .. ,, ."._, -- '~- .. .. ." " -.. , -"t- ., '-' ,-,,--, --._'" "1--'" , •• - .• - --
,. : ATP 8! 11 Bpi 12 <I} !,' 39 I 129 
, 200 1Iift.r. (a.c.) i 1.1.4 SO!,!". i -..,..-0 . '4.64 I i.14.1 
- S -:~~~~(;.c.) 8 ~".-Ji~-.!~~~. ··l~~~-f ·Jg~S r ~.S - _ .... 
" ..... _ L~~l~_ (!~c.) ., .~. ~""'"' '- _ .,., _". _ .. _~. ., i .\ 
i i! " 6 : Ipreniuid 7' 65 : Ep1 106 ).pi 7S :~s~~!,(f:L ........ i __ .. ~ ..... _~:~ i ~~~:.l.!S.7 .. i .. !Wl_-I_~'~ ___ . 
7 : Pbent.olaxi ne (legitine} 8! 4S i Bpi I 59 I 13 i 29 
. S ~ (s.c.).S mdJg i.v. j t1.78 I SOVlg. I 1.3.47 i t2.Sk I S4.S 
• I • I _ _ ,', ,_ .',.. ._ j,, __ ._, , __ .. ' ,_. _" •. 
-_. S·- .Ph';~~_~-" ,-- ;--"8' --. r'$b ",-- --r- . ~~ ··l---s~"· -- B ; 
1 (I)lbensyl:tne) . j t.2.;; : SO:fj'Kg. ";tll.9 i.3.29 
! 2 ag/Kg (~.c.).l ag/Ig i'.,,- .1 .. ___ .. ," __ .. " . __ ._" ,_ ,~, _ __ ___ '. _____ . __ .. ", "._. ___ .. 
"-'~- '-- .. '-.'.,-- ~-,-- Y""~--' ,~_~~ .,"""..... -
... 1bJ'radne was administered daiq for 8 perl.od or 2 weea prior too exper1ar:'lta. 
All other subcutaneous (SeC.) a6rdnistratians vere made 30 minutes prior to epinephrine admi."!1atraUon. 
Ipra:duid (a.c.) was in additiCX1 acin!nistered 24 hra. prlor to group 16 a:per1ment.s. 
IntraTenou (i.v.) drug pret:reataent ... ad1Iin1aterecl 5 a1nutea prior t.o epinephrine 1ntuaiona. 
Group 
1 va 2 
1 VB J 
S~at1at1cal .Anal¥81a of D1astol1c Blood Preseure 
Chang .. In Table 2s. 
Preasor Level Net Inoreue % Increase 
N.S. M.S. N.S. 
0.01 0.05 1------+---------11----------- r----.-.. ---.---......... ------I 
1 va 4 0.01 N.S. (0.001 
I------·-·-I---,.-----····.··--!---------,..-.-- _._-.. ".-.. " ... ". -.--... -------.--.----i 
1 va 6 N.S. N.S. 0.0$ 1----------_ ... -_ ... -.--... ---.-.--I--~ .. _-------... - ----.-----------... --_.-.--........ __ ..-
J--__ .~~~ __ !..-_ .. _t._ .. -._.5° __ -~~-- --- . -.... -.. ~ .. ?~---.- -~ .. .... ~ .• ~~.-.. -....------.----.. -
1 VB 8 J <0.001 I 0.01 0.0$ 
-------- ----.- -.. -.----~."'. r---···--· ..... ----
.3 Vel S I (0.001 t N.S. N.S • 
. ---._--... ·-----t-·· _ ... _ .. __ .. _. - .. _-_ .. -... ----.-.. ---.-.. ---, ... -.. -.-.... ---.. ----. -.--... " .... ~--.- .. --
_. __ ! .. _~~_a._ .. _L._ ... _~_.S~ _____ ~ _____ N •. ~ ___ ._ N ._~. . ____ --1 
N.S. • Not Significant - probab:tll:tw level greater than 0.05 (S%). 
Table 3a 
'Effect of Intravenous Intusi.on of Epinepbrlne (EPI) or Norepinepbr1ne (D) Following 
Pretreatment bT Varioua Drags on Mean Blood Pressure in the Unanestbeti.sed Rabbi.t 
Group! Pretreatment No. of em trol. Level Pressor Pres.or Jet Increase % Increase 
Exps. mm.Hg. Drug Response mm.Hg. t----------·--· ... Rg. .... - 1---, -1 Saline 8 ~1 s~. ps ii.6 ~.S7 1 ml./Ir. s.c. I -S.S -lO.2 
- .. -. _w. __ ._ ·-----.. --T- - .. -
2 Saline 9 , ~ II 1f7 48 ~.83 1 mJ./Kg s.c. -2.45 SO't/Kg. %.4.06 t2.74 
-
J Tlwradne* 9 117 Bpi 171 52 47 0.1 mg/Kg (s.c.) :'3.13 SO'4/J.g. 11.7 !J.7J 1:4.67 
__ ._ ... r. o. ~ --... ----+~. -. 
-' 
" 
k .uP 8 40 Jpi 85 45 lO9 200 IIIfV'Kg (s.c.) 1.22 SO~/Ig. S428 4.6 11.7 
.. 
5 ATP 200 ~(8.C.) 8 ~.89 ~. If.;.o 1~.86 62 +T.hyra:Id.De tlB.O 
0.1 ~~.c.) 
- .. 
. __ .-~.-.-.-----. -_. 
6 Iprordaid 7 76 Ep1 116 42 56 )0 -.fig (s.c.) t4.1 SOJ/Kg. :'11.5 ts.4 !9.) 
7 Phentolamine (Regitine) 8 51 ~ 65 13 26 S mg/Ig (8.C.)+S mg/I& i.~. tJ..97 5O~7Ig. tJ.lU t2.1t3 :t3.8 
-
.~.-- .. .-.---
8 Phenaxybclzam1ne 8 61 Ep1 68 10 16 (D1bensyline) , t.2.S 50/Kg. tS.2 t1.98 t2.94 
2 ~ (s.c. >+1 ~. i.v. 
-
.- .--. 
* Tb.Jradne was administered dai:Qr far a period of 2 weeks prior to exper1.ments. 
All other subcutaneous (s.c.) ad1d.nist-raticns were made 30 m1nutes prior to epinephrine administration. 
Iproniazid (s.c.) was in addition adm1ni.stered 24 bra. prior to group 16 aper1.ments. 
Intravenous (i.v.) drug pretreatment was administered. S minutes prior to epinephrine intuaions. 
.. -_ .. ,----.. --------------1' 1 
oroup I Praaacrr l'.ev'81 net. Increase I ~  
-......... ~,., -""'" .. -- ..... "'-.... ~.-'-"'-., .... I--....... -."-....,-----.... ---~-r .. --· ... ~---- ..... -,..,.'-,,- "' .. _u""· ....... _ ... ......--· ___ ., ............ ,.. __ '" .. ~ __ ·~ ... ~ ... _ 
1 ! I 1 .. 2: 1.8. ; 1.8. 1.3. 
----"".-,. -+-., .~. 'i--. ----·--·-,t---~-·: ,.-.---.----.. -
1"., i 0.01 ' NtS. ' I.S. 
I. I \ 
I------...-...,:;.-·----"----·---·T·~·-' .---.. ~.-------I.--'"--.-~ -.----.~---- .. -- -
1 ft t.: 0.01 I I.S. I ~ I . I -'''-'--'-''-'--'''l-''---~-'-~'-'''-'--'"'-''''l-~-''''·--·-.. ··-1'--·------·-··--·-·--· 
1 ?8 6 '1.8. . I.S. ' l\f .. s. 
-_.. I ~.~." . t--- "'---'~-'1-' ------.. -.... -.--
1 .... T i (0.00l i (0.001 . o .. m. 
---·--·t--··--.. ---------f------'1-------.. -·~-~- .. --··-,-·----I 
1 .. 8 (0.001 l{ 0.001 i (0.001 
. ---"1 _. · .. ·--··-·-·4--->·~-·-· .. ·---------·--·· .. ---·-.. ·· 
l ... S o.as ' 1.8. . 1.8. 
-_ .. -. . . ---1---- _._._--t---_. --·-·-·----1'·"·· .. -. -... ------.. -.. ---.--, .. 
., 
... 8 1.1. I 1 .. 8. ft.s. 
i l 
--------'-_ .. _--
~ 
'fable It. 
Levels of G~ogen ~ Aorta and Skeletal Muscle Followmg 
Acute I.V. Epinephrine (5b¥l~g.) in 24 hr. tasted Rabbits. 
n Aorta Skeletal 11usole * 
, 
1. SaUna Controls 9 67 t 6.6 rags. • 122 t 18.1 !lga. % 
2. 2 brs. atter !\pinephrine 8 ,1 % '.9 " 83 t 21.3 ft _ .. 
.3. 4 hre. after lpinephr1ne 8 40 t 3.46 It 41t 7.1 ft 
----_.-
4. 8 hrlll.. a.t'tGr Epinephrine e ,9 i 6 .. 6 • 71 t 1,.8 tt 
, Values Aorta Skeletal lIuscle 
I 
1vs2 N.S. I N.S. 
1va) O.os .001 
1"4 N.S .. .~ 
* 
Source or skeletal muscle was inner aspect of the thigh. 
W.S. • Not Sign.i..f1eant or A p value> 0.0,(,%). 
S7 
Table !) 
Effect of Subacute (2 't'ft.) Administration 
or F,pinephrine and Epinephrma + Thyroxine 
(XI Tissue rAVels of Gl3"cogen in the Rabbit 
n Aorta Skeletal t-tuscle* 
1. Saline Cootrols (I. V .) 1 cc/l.g. 8 lOh. t 11.2 •• _ 182. t 41.6 mgs •• 
2. ~. ( •• c.) 0.1 mg/(g. 8 Sk. t 13.6 11 253. , 20.9 tt 
3. Ep:mephrine (1.1'.) SO,//r.&. 8 108. t 11.4 11 172. t 34.3 .. 
h. F.p1nephrine (1.1'.) SOI/Ia. 6 ~9. i 4.S6 It 138. i 2).8 fl 
+ 'I'h1roxine (s.c.) o. mgfrg. 
. 
- --I-" 
_ ...
P Values Aorta Skeletal Muscle 
1"2 i.8. N.B. 
1 va.3 N.S. N.3. 
ln4 .. 01 ~l.S. 
* 
Souroe or skeletal muscle ~ae ~~er aspect o! thigh. 
I .. V. .. 1ntraV8llGUII 
s.c. .. subeutaneoua 
N.S ... Not Significant or p value > O.O~(5%). 
Effect of Subacute ( ! wk9.) Ad!dn1.8tretim of 
Epinepbr1ne and ~...nephr!ne + ~1zl. CI'! T1eaue 
Gl.ucose in Ute Rabbit 
---------- '----;---r-------.----:-----.---.~---.---.'--I ft A ...... I I OJ..... : Ske1etsJ. lfu80l.e 
,--,--.------ t ".-t- .~~--,---.---."".-.-.---
__ ~ .. _~lin.~~tr~~~~.~~.) 1 e~/Kg·1 8 I 41.1:' 3.'1.~." I 91.8 t 11~S~~;; 
2. 'l'by:rald.ne Ca.o,) 0.1 rogJr.g. I 8 j ~.9 !t 6.96 " 1136. to 20.9 .. 
. .. -, ...•. - ''''"-'''''''<~-'''''-'''~"'~'''~''''- ~~'''~_''V_' '< ""_--..w .... " "" ........ --,-.--~.""~~~>"'~", "-,...·..,·""' .. -·~-<~,~-"' ........ ---·1-· . 'V_--,.~", 1 '-' -
3. F.plnephr1ne (i.v.) SOtlKa. i 8 I 97.0 't.1O.6 .. 11S6. t 16.1 .. 
-.---.------.. - .. -.-~-_4 .. --.-J-- ~ .- t-··_-_··_-_·-_·· .. n • 
4. Epinephrine (i.v.) SOllrf- I 8 i 70.1 ~ 1.81 .. t~ .. _: .. _9.~_,.~_ f---.+-~~.! _q~~.!"8!&~_ .. !~~!} ). . .L ..... _ -- "," ...... 
I I I 
I I Aorta ! Skeletal MuNle I -.. ,-1---,. ---.-... " ··-· .. ·~---r ·"W·~ ___ ._· ... ' ·w ....... --.. .. 
i 1 w 2 I I N .8. I H .5. l----.-------.-.. - .. --.- --t-_·_-..,..·_--_ .. " """"----.-", .. _-",, .. -----... -; - ................ , .. -............... " ... --.. .. L 1 va 3 I t ____ ~O~ __ ~ __ I_-.. -_--.--.... -~OS-.. ------
L ______ , . __ ~~_~._I L __ ..... _·~~ .. ~~~ ... _ ..... _ .. 
PValuea 
1.8. • Not SignIficant or P TIthe> o.Os (~). 
"lable 7 
Etteot or Subacute (2 wk.) Adtdnistrat10n or 
tp1nept!:rizle ane !ptrlephrine ,.. 'ltqrc:ad.r.e aa. 
Tissue Lactic Acid in the Habbit 
,«'... . .. ~ .• -....... '.' ", .... , •.• '-..... "-t" ..... , "" . .. - r' ..., ...... ,~"., . 
In! Aorte I Skeletal }iucle 
, .... , •. - .. ,«-, - ,-._ ••. - .• " •• _- " .. '.'" ... ,-_. -"",,"" ""-' .",. __ . ,-" ••• • -j-'. '--1" '-_ .. _-'- .. _,., . " .. ,.,-,. ,-,~-, -." '-'"., ,., " .- -. ..'" 
._4 ... ~_~.~~ .. (1~".) ~ CO~.~~~:~.=.~.4~.:C+!,3~ •. :.2~~IIp'~ 
2. ~~~ .~ •• o.) 0.1 mg/Ia~-l 6 i 59.2. t 7~38 .-~--v.~ t 2~~4 . ~_~_ 
r-~--.. -.-!~~. ~~~Y.) SO ('c--. I a i ~~ : ~.~_ .. I 408. ! 3~1'~_~~_ 
4. !P;:::=: ~!:::~ ~~. I 8 ! 14.1 t '.9 It i 377. :t 25.2 It 
1---""--""" ,.""",., "'.--'-' "~.' "-"'" ~'~-'-'-"-'.'-'-'- ""----' .-J-- -----,-~,---- ---.. ' ... ",_ .. +,-,-,-.---,-~--.. ,,-""'-
I I , , 
i l I Aorta I Skelet.al iiucle 
l;~";'T' N.S. I 11 .5. 
, , 
'~"-'-'- • .f ""'-"""--1----"""'---'--""'''' 
1 VIJ l I I.S. ! ll.S. 
r-'----"--·'l-;;-4r-·~;:·~~'··"-"'--··--r"·'" "·N.~'. "'-
----,------"'- ... ",,-.. "- .,--,.",' •.... " ... _' ... _-'._-,,,,.,, ..... ,.-.' ... ,. " ...... ". ,-
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Table 80 
Effect or S-ubac:ute (2 t;1k.) Admird.stratiro or Epinephrine 
and Epint"Jp}J,rine .. Thyroxine CL. Aortio IDR (tactic 
Dehydrogenase) Levels tn the ltabb1t 
n tJn'.ts/lOO mg. yet Wt. Units/mg. Prot-air, 
1. Sa.l1De Ccot.rol8 (Lv.) 
1 cc/Eg. 
8 7." : 0.880 1.46 .t 0.17$ 
2. 'l'hrr:7le (s.e.) 
o. 1II&I'1a- 8 5(2) t O.~4 O.98¢ 0.126 
). ~in~e (i.v.) O~g. 8 6.80 ~ 0.70) 1.29 : .02It6 
4. Itdnephrine (1.v.) 8 6.80 t 0.0211 1.3' t 0.l.l9 
;0 fF4,. 
+ 'nl11'OX1ne (s.c.) 
0.1 'If'{!/r.g .. 
PValues 
1 VB 2 N.S. N.B. 
1"f'53 N.S. li.S. 
1 VI'S 4 11.8. N.S. 
i.v. lilt 1ntra:venoUi 
a.c. • subcutaneoue 
5.S ... !tot Significant or p value > O.os (S%). 
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Table , 
:ll'l the Rabbit 
1. Saline Contro18 (l.v.) 1 eo",. 8 
--, .----------
14.6 t 0.87 p.H/lIXJ 111". 
----------1 
1O.74t 1.>2 .. 
). Epinephrine (l.v.) sortra. 8 . 14.1 t 1.41 .. 
---.------+----.~-----------------------
a 10.9 t 0.16 
I I I 1~I_P __ v_ah--8~a----------~-----~ 
I 1 va 2 O.V) , 
J.vs4 I 
i.v. 1# intravenous 
N.S. • Not S1a;a.1.fioant or p value ) O.os (~). 
tabla 10 
In Vitro c~ Proc1u.ct1al b.r .lort1e T1ana 
lraa Gluoo8e-6-Cllt. ~ .. PhoIIpbate Butt .. 
11 ~.Wetft. ~.DI7wt. 
z per hr. z per hr. 
~ CCIlVola 14 20.28 ! t.ll 71.906 t 8.2 
2. Epinephrine 14 28.1 t ).1 109.10 t 11.6 
-
~-
3. Ep1nephr1l1e + .lTP 6 12.28 t 1.14 SS.8S + 3.87 
-
- -
4. Epinapbrlne + PheW_De 8 ll.19'& 1.)2 S:h9. t 1.2 
...,-" 
_______ e_ 
S. Epinepbr!ne + Phen~ 8 18.21 t. 2.81 80.,. t 13.6 
-- - ~ 
'fable ot P Valuea Wet ft. BUD Dry wt. Baa18 
Group P Value P Value 
1 va 2 .OS .os lva) <.001 <.001 
2va4 <.001 <.001 2vaS .oS R.S • 
2va) .01 • os 
1n4 .01 .os 
lvaS I.S. I.S. 
4nS B.S. I.S. )nS I.S. I.S. 
b f'oll.ow1ng dra& CCIlCCltratiCil18 were emploTed 111 the incubat1cD medium Epinephrine O.SO/ml~ m 2 mg/ml 
phctolud.ne 0.1 liaIlIIl. ad phenfDTbenumine 0.0) mgfml. 
I.S. cienot_ lot S1p1t1cant or a "P. J.aorel greater than S%. (O.os) 
Table JJ. 
In Vitro C~ Productia1 by .lmic fta8\1. 
Frca Gluc._ 6-014 Xreba-R1nger B10arbanate Bufter o.~M/ml of 
Gluc08e Added 
D~.Wetwt.. D~ me Drr W\.. 
x per hr. x per hr. 
n 
.. 
_. ----------+-----+----- -
1. Controls 8 2.146 1'. 0.)40 11.62 *' 1.110 
-_ .. --~- = - -----.-.. -- --1------ ,- -. ~.-
2. Epinephrine 8 11.90 t 1.42 46.77 t 6.S 
.. 
-.--------- .. -------+---.---t--------------I~ 
3. Epinephrine + m 8 4.730 to 0.SQ8 1.8.S2 t l..6S 
----.-~ .• - . ._- -' _ .-.. -~.------.-----.,-
4. Epinephrine + PhenWlurine ;1=+ 1.072 t 0.174 4.268t 0.64 
-----,---,--- ... '_. ----- ' __ . ____ ,.------1----- ._--
S. Ep1nephrin.e + Ph_aqben&aJD1ne 8 2.502 t. 0.217 9.397t. 0.924 
_._- --.-.-- '--. ---. ..----f---'-----,------·-----I'O" 
vJ 
P Taluea wet. ft.. Bu1e Dry ft. :SUa 
-- -,---------
P ftlue P value 
lft2 (.001 1ft2 (.001 
2ft) <.001 2 .... 3 <.001 
2ft4 (.001 2 V8 4 ~.OOl 
2ftS (.001 2'V115 .001 
4nS (.001 4vsS (.001 
1 va 4 (.001 1 V8 4 <0.01 
1veS B.8. 1'9'85 N.S • 
--
. _-
!he tollow1ng drag CClDcentrationa were eap10red in the h1cubaUm medilDl1 lp1nephr1ne O.~~ml, .l1'P 2 mg/ml, 
pbet.oludne 0.1 ic/ml, and phenCD:1'beDzaR:ln e 0.0) mg/m1. ' 
N.S. denote. Not Significant or a "pit level greater than SJ. (O.os) 
Tabl.e 12 
In Vitro C~ Production by Aortic T'1.uue 
(2 wk. ~e P:rRreated Animale) 
01ucoee-6-C14 Ireb~er Bicarbcnate Bafter 
o. ~ml of Glucose added 
---_. 
D D~ agWet.wt. DPK/lOQ JIg D17 wt. 
x per hr. x lO3 per hr. 
,"----.- ,--,,,,-,- --,-
1. Controls 8 6.072 t 0.614 22.8S t 2.34 
1---' '-
.._-,,-
2. Epinephrine 8 ll.38 t 1.49 41.71 t 4.62 ,_ .. 
,---- ,-, ,,--
3. Epinephrine + A'tP 8 12.39 t 1.41 46.70t S.61 
- -
,-
- "---
4. Epinephrine + Phentol.am1ne 8 .3 .203 t 0 • .34S 12.49 t 1.30 
-~---1--'_" '--
S. Epinephrine + PbenCll:l'benzu1ne 8 6.091 t o. S1S 24.34 .. 2.ll 
-
,._ ..... '-,-'"" 
Table or P valuea Wet \1\. Baa1a Dry wt! B .. ~_ 
1;;"2 0.01 0.01 
2va) N.S. H.S. 
2'9'84 (0.001 (0.001 
2 .... S 0.01 0.01 
1 .... 4 0.01 0.01 
1 .... S H.S. B.S. 
" .... S <0.001 < 0.001 
!he foll.otdDg drug CClDCtI1tratiCll. were aployed in the incubatiCll medium Epinephrine o.Sr/ml, A'l'P 2 'llig/ml, 
pheto1urf.e 0.1 muml 8'1d phenGll'benzam:Jne 0.03 mtt/BiJ.. ' 
'.rbtro:dne 0.1 wc/Ii; 1f&8 adDdDisterec:l aubcutan"'ll' each dq tor two weeks. 
W.S. denotes Not Signllicant or a "p. leYel greater 'thm S%. (O.os) 
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'fable 13 
In Vitro e~ Production by Aortic 'f1aaue 
From. Glucose-6-C14 Krebs-Ringer Bicarbonate Butter 
Kreb....ain&er Bica-batate Butter +O.~ml.CIhooII 
! 
I II. I D~i:mgt\tlet Wi;. ~ fII{:.D1'7 Wt. 
'x "'liel' 'im. x'» ___ 'llr ____ 
-
n.89 t 1.73 1, C (IRB) 6 31.51 1 4.86 
-- --'-----j----_. __ . ... --~-.~-.. ----,- ... -.--r-'--
2. ]£pi + (KRB) 6 12.11 ~ 2.33 34.65 t ,.90 
-- - -~ .. ----1----------
3 •. Bpi + ATP (DB) I 6 9.26 * 0.86 2).46* 0.63 
,._-.--- + _. /'" ... -n 
-----~ :t6-~ t--._._._- - ~------.-4. e 2.84 t 0.61 8.1331 1.04 (IRB)* 
-_. 
,. ATP (m)* 6 3.61 * 0.26 11.36 * 1.S3 
-.-
-
6. Phmtolam1ne (DB)* 6 1.45 :t 0.11 4.03].t 0.,8 
---
1. Phcuq-benlludne (DB). 6 2.49 * 0.1.&3 6.86O't 1.19 
- -
8. Narep:l.nepbl"1n. 6 3.41 t 0.51 12.86 t. 2.) 
----------~---.- t--_._. ----.---- _.-
P Valu •• Wet wt. Bui. Dry wt. Bas18 
Group P Value P Value 
... ,..---.... -- -.,-.--.. -.---.,~------ -.-~-~---.-
lft2 If.S. If.S. 
--~--------- r--' 
lft3 N.S. I.S. 
2ft3 I.S. I.S. 
---
----. __ .-r---'---'" 
4ft5 J.S. H.S. 
4n6 Jt.S.(O.l) O.OS 
4 ... 7 I.S. I.S. 
4 .. 8 I.S. N.S. 
!he tollow1n~ ~ cC'llcen trationl were aplored in the incubation medium 
Ep:lnepbl"1ne .S~ al, ATP 2 ""'al, Phefttolaadn. 0.1 ma/ml and PbSlc.'Jq'bensuine 
0.03 mgfml, lorepinepbr1ne O.S;/ml. 
N.S. denotes Not Signif1cant or a tiP" lsYel greater than 5%. (o.os) 
Table 14 
In Vitro C~ Produeticm by Aortic !ialUe 
Ji'rool Gll1cose-l-C14 Kreba-Ringer Bicarbona1ie Butter 
+ O.S~K Glucose/al. 
2.. Epinephrine * 
! n 1DN/100 JIg Wet wt.1 nPKlloo mg DIT Wt. 
:'It lOJ pt;r hr. I x' 10l per hr. 
a I 2'1.4 i 3.76 100.8 ill.) 
~--------------------------+--+------------~------------~ ). Epinephrine + m .. a I 2).0 t 2.42 86.9 i 8.6 
4. Epinephrine ... Phent.olamine * ! 8 I 18.0! 2.7.3 I 66.l !. 1O.S 
7. Epinephrine l6 7.741 1.2,3 I )0.8 i 4.90 
1--._-.... '-"-- •.. -.....•.••.. "~r- _._ .. _-.. _-- -., .. -------... ._.- --.-.--.•. - .•.. --.---.--L-.---------
, P Vall1e. I Wet Wt. Balis Dry lit. Balis 
1..,.2 N.8. I I.S. 
l 1 va ) w.S. I w.s. 
t 1 V8 h. I.S. N.S. 
! l .... S W.S. ; N.S. 
ln6 J 0.001 I 0.001 
1ft7 I .001 J .001 
The fol.lo1d.ng dru& CCIlCttD.VaUcaa were .,loyed in the :LncubaUon medium 
Epinephrine O.sr lal, A'tP 2 mg/rel., phtotolaaiDe 0.1 ms/ml, and. 
phcO'q'benza1.ne 0.0) arlal. 
* Obtained from rabbits pretreated. With 0.1 mtVlc. tb1'rax1ne 8.0. for 2 "ka. 
K.S. denote. Jet S1gn.1t1cat Or' • P l.,el grea1ier than S!l. (0.0,) 
Table 1$ 
In V1\1"o Ip1ne U. 1.. clh InoorporatlC1b 1.i.-t.o prote1n by Aortic 
T1saue trOlil Nomal and 2 Wk. ~. Pretreated Anima1a 
n DPH/lOO JIg. wet wt. 
x ].OJ per hr. 
,---~_, __ ~"'_,' __ ._~. __ , ___ ,,_,_~ .. , '~----"-'-"" .. ,-,--L---, . .-_- --~-,-- .. --.. - -- .. '" 
1. Normal Controla \ 4. 32.72 t 4.1S 
-_._-_._-- _. __ ~ ______ .w,·_. _______ · -1.--~ .... ----1--.-.. ---.-'-·~--'-·---·-'-'-'----
2. Epinephrine (Ncmaal Anhl&lJJ) ! 4.! 12 .6S ! 1.67 
------,..--"'-.-~.-- ~ .. ,,~-.--.-.-, ... - .. --.. ,,-, .-. ..... --1--. --'.", , .. _-_ ... __ .. ,",-, .. "",,,,, '.""., ,.' ,. 
3. '.~e Pretreated Controla* i 8, ll.20St 2.$ 
, , 
_..".~, ___ ,_._", .... ,_..... .._ ,", ., ...... _~ ...... _"-_ .... .,.. ..... ~> .. ,_ ...... " ~" _____ ~. __ ......... _ ".n ."' .... _~._" _~ "".,. .......... ,.-~.,.,.,... .... 1 .•. --.~~,-.,.-~ ..... ~ ...................... ---,----"'.--...... , .... y--,~· .... -.~-"' __ ,. "-'-'~ '-" ......... ~,~-.~ 
4. Ep:ineplU"1n.... 1 6 j 1.oS8t 1.22 
! j "'!""' -,,".,,"' q ,,'q.,..,...--.- .... .. __ ~_,. __ •• ~~~. -'"v "'4 '_'''~T _ ...... __ .'_ ~ ~., ~ ___ ~., _~"" ._" .. ""'.< ... ~." , .... -...... ~ ..... ~" . ",~.". ","' ___ .. _,,_.' ~~ ,._ < ..... -«'<. • ,~~"' ._.,< _~ "..... • ,e~, 
~ in" i 8 I ... 
:;1* Epinephr • + ATP ! I 10.01 ... 2.27 
:-~~,~-~~~~~~~~~~-Ph;~~;,~ ,'-.J ~.~:.~·-r,.~.· 6.6Trt.'~.~. ,. 
7 • Lpineph~'ine + Pheno.qbenuraine i 6: 1.217* 1.14S 
f ..... ·0" ... • , .... " ''-_ ... "". __ , ......... "" ... , ____ ."~ .. " ~_,~. __ , ~ .. ~., ......... «..,""""'_,,,.,..- ........ ' .... _~ ,~..... _,. ... ~ '~_h' 
PValn. 
1n2 0.01 i 
--.~.--,. '-"--'----r--·--~--·-
1 va' i 0.01 
-,----~ .... -~-.'"'--"'.------ ... ""'+ ... ---, .... -...... "'>~.---...... 
2 n.3 I 1.8. 
---.. __ .. -_. , -;~ 4'-T--- o~·ooi.**-
,,--......... _. --'i'ft' i T-··~-~s .. , >, •• 
"-"-"~"--"., .. ' -.. _.- ..... 1' ..... '" '-"',,_ .. ,,-,., 
4 va S, o.os** 
--..... -----~- ........ .., .... - ... -,.."j. .. ~,..,.---,,,---~- ,~.~ """ .. 
h .... 6 I I.i. 
i 
-'-"-'-~-" -",'-"'~'"'''' '''".' -", , .... _ ..... _- ' .. 
4 .... 1 I I.e. 
H Uainc paiNd dUferenc .. uthod 
* f1aaue obt.dned f'rcm _tala pretreated tor 2 ween with 
0.1 mg./Ig. a.c. of 1.'hyrod.ne .. 
!he foU.old.Dg drqa ccmoentrat1ona were eBlPloyed in the incubatlcn medium 
EpJ.nephr1ne o.S- llll, AT!' 2 rarlml, phentolaa1ne 0.1 ar/alt 8t1d phcoq'bensudne 0.0) ";'IAl.. 
l~.S. denotu Not 8igrlif1oant or a "p" leV'e1areater than S_ (O.os). 
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Chapter V 
Discussim 
Medial Sclerosis and Vasopressor Ph810mena 
Several investigators have suggested that the medial sclerosis 
following an epinephrine regimen 1s a consequence of the vasopressor eftects 
of this drug (Lorenzen, 1961, Tqlor, 19S1u Waters and de Suto-Nagr, 19SOa; 
and O'SulliT8ll, 1962). Although this positim is not without merit, it is 
quest1mable whether such a narrow interpretatim is adequate to explain the 
nrious observations made in this report and by other investigators. The 
presfllt studies en vasopressor and metabolic erfects of epinephrine and 
thy'rox1ne suggest that a broader .. sessment or the role ot these two drugs in 
medial sclerogenea1s might be more consistent with experimental data. 
OUr own .. sessment or the vasopressor theory or m.ed1.al arterio-
sclerosi8 has b8fll condi timed by a paucity ot critical exaudnations ot the 
vaaopressor relationships involved. Qualitative mention or the potenttation 
of epiJlepbr1ne t s preuor actian by t~e has been invoked by O'SUllivan 
(l962), 1orenz81 (196l.a and b) and others as categorical evidence that 
epinephrine induced medial sclerosis is primari4r a cmsequenoe of the press 
aotims of this drug. Sec~, it was assumed that drugs which potentiate 
this pressor .rrect will increase the incidence and swenty or the ar$erial 
lesions. Conversel1', it was assumed that drugs which interfere with the 
pressor actions ot epinephrine will provide protection against arterial 
lesiens (O'Sullivan, 1962; Waters and de Suto-Nagr, 19,Oa, and Lorenzen, 
1961&, b, 1962a, b). 
Examination or the preHl'lt data suggest that some discrepancies 
exist between the ability of a drug to prevent rise in systolic or diastolic 
69 
pressure in acute experiments and its ability to prevent epinephrine induced 
medial sclerosis. Pertinent to this observation is the data in Figs. 1 .. 9 
and Tables 1 .. 3. Thus iproniazid pretreatment at the· ·dose employed 
decreases the net and percentage mcrease in systoliC pressure following 
epinephrine but according to O'Sullivan (1962) on a subacute basis greatq 
augments both the incidence and severity of epinephr:1ne induced lesions. 
Ccnverse~ ATP which does not significantly- inhibit the net or percentage 
increase in qstolic pressure caused by epinephrine infusion is perhaps ene 
of the most effective agents known in preventing medial sclerosis inductien 
by epinephrine (Davis et al. 19S5). Phentolamine and phenax;ybenzam1ne 
produced an inhibition of pressor response to epinephr1ne to an a.lm.ost equal 
degree (Figs. 2, ), Tables la, b). Yet, according to O'Sullivan (1962), when 
administered prop~laoticall;r on a subacute basis phenoJr1'benzamine is rather 
ineffectual :in preventing epinephrine induced medial sclerosis while phentol-
amine shows good activity in this regard. Norepinephrine, which in the normal 
animal produces a slgn.if'icantl3' lower incidence of medial damage than 
epinephrine, Friedman et &1. (19"a, b) produced net changes in systolic and 
diastolic pressure which were sindlar to those obserV'ed with epinephrine 
(Figs. 2, 4, Tables 1, 2). 
Acute diastolic pressure data similarl3' do not appear to be f'ull¥ 
cCI'U.istent with a pressor theory' or medial sclerogenesis. Iproniazid 
pretreatment at a dose reported by O'Sullivan (1962) to 1l1tensify epinephrine 
induced medial sclerosis did effect a net increase in diaotolio pressure 
after epinephrine aha] 1 enge as compared with ccmtrols J however, this inorease 
wu not statisticalq' significant (Tables 2a, b). 
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Net increase in diastolic pressure produced by epinephrine, in ATP pretreated 
animals, was virtuall,y identical to that observed in saline pretreated 
controls (Tables 2a, b). If the increase :in diastolic pressure in ATP 
pretreated an1mal.s is expressed as a percentage increase the rise following 
epinephrine in both systolic and diastolic pressures exceeds the values for 
thyrox:ine, which is reported to accentuate the medial damage produced b,y 
epinephrine (Michulloich and Oester, .. 1951). Although the above data raise 
questions regarding the sole importance of systolic and diastolic blood 
pressure changes following infusion of epinephrine as etiological factors in 
medial arteriopatby it should be kept in mind that these results were obtained 
in acute experiments. It is entirel\Y posaible that subacute administration 
ot these various drugs could coneeivabl\Y alter interpretation of the 
etiological role ot pressor effects • 
.Ana:qsis of heDlOdynamie data bued on the pre-infusion systolic 
and diastolic pressure suggests scme correlation ma;r axist between the 
ability ot a given dNg to increase or decrease sY'ltol1c and diastolic 
pressures and the ability of a drug to intensi.t'y or prevent medial arterio-
pa'tbJ'. Thus AfP and phentoludne, reported to be of value in preventing 
epinephrine arteriopathy, (Davis et al., 19$$, O'SUllivan, 1962) decreased 
systolic and diastolic pressures to a greater extent than the other drugs 
studied (Tables la, 2a). Conversel\Y, th3'rox1ne which according to Michulicich 
and Oester (19$1) augments epinephrine arteriopathy was most potent in 
increasing systolic and diastolic pressure prior to epinephrine infusion. 
However, iproniazid at a dose reported by O'Sullivan (l962) to augment 
epinephrine arteriopathy, decreased pre-infusion systoliC and diastolic 
pressurefJ (Tables la, 2a). 
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'fbWl, mod1f1cat1on or the epinepr..ri...'1e pressor respc:nse toll..ow1ng va:rious 
drugtJ does not appear to be who1J;y consistent with a hemodynamic etiology ot 
epinephrine arteriopat.J:v; yet, the possibility cannot be excluded that other 
tacets or extensions of cardiovascular studies could show positive 
correlati0ll8. 
Recent studies tram another laboratory question the sole importance 
-
of' vasopressor effects in producing arterial lesions. Gu'tstein and Cooper 
(1964) have reported. that intravenous adDdnistratim or Vasopressin either 
1ntravenousl¥ or intraper1taneally thrae times wael:ly rar a period ot 6 to 
11 weeks did not produce any' observable :u-terial lesions. When, however .. 
this regi.'I1el1 was supplemented by ooncmtant oholesterol feeding, medial and 
intimal caloif:tcation was observed in abont )OjC of the animallh Outatein 
(personal camn.lltlicatiCll) has indicated "We are in cOl1p1ete agree.1tl.ent with 
your statement that, factors other than vasop't"88sor etfects alone !Il8T plq 
an iq>ortant role in the development o! this type ot pathology." 
A similar position in regard to medial sclerosis has been taken 
by Milch and loxtennan (1964) who have taken issue wi ttl Lorenzen t 8 (19S9 .. 
]96la, b) suggestion that medial sclerosis following epmepbr1ne is II 
cCIlsequenee of the vasopressor etfects of this drug. Milch and Loxte:rman. 
(l964) bave recent17 stated that in their op1niClll "Lorenzen t s data are 
subject to add1.tional 1nt,erpretation :in that his results also support the 
Jv'pothesis tba.t epinephrine initiates and B.ggntVates a detect in the 
"biochEmical architecture" of aortal wall whioh rende" it susceptible to 
degenerative cbange, and that the defect 1s manifested bT an alteration in 
aortal IlUcopol¥saccharide metabolism". In the analTa1a ot their studies CIl 
lIUCopolpaechar1de metabolial of' the rabb1t aorta JW.ch and Loxteraan (1964) 
oCllolude, "the data support. the hypothea1s that epmephrine induces a detect 
111 the b1och~ cal arcb! t.ecture of the arterial wall 'llh1ch rendere 1 t 
auaceptible t.o degeneratbe change". 
Further analysis of significance of presser effects suggests that 
11' arterial damage is a sole or primary emseqnenee of vasopressor ettecte 
a co~e1atian should exist bet17eel'1 arena ot me.."tfmal. pressure and loca1:!.£a-
tim of lesions. 'the presl.':tt'!"e pu1so JnOVinC toward the periphery at a 
velocity considembly 1.n excess or the vl?loe~.ty or eorpuseu:t.ar elements ot 
t.he blood causes a. rebound of blood from rec'_Of!s of sharpJ;r inoreas:J.ng 
:resistance, thus giving rise to a decrementing d:tphaeic eentripete.lwav8, 
(wiggers J 19S'-'. Smce this centripetal wave and the preefml"e pulse are 
both present in the same system of "1a1bea'l J they &!nlJ'lm&te effecting a major 
alteration in contour of the pressure pulse. !he propagat1cn of th1a 
refleoted pu.lse 113 deeremen.tal. '!herefore I a greater 8Dq)litude 18 aTailable 
at the more distal portions of the arterl.al tree givtng rise to a greater 
net \lave ~11 tude. At points lUOl!*e prad.mal to the 't'entr:1cle the attenuatecl 
reflected wave caulln less ot a mod:1tlcatlon of the 't'entrtcular pulse and 
'the rosultant arterial pulse 18 louer in magnitude. 
'!'hus cctrV7 to a:pectat.1ona the aapl1tud.e ot the prunre 
pulae recorded at points JIlOJ!"8 distal. to the heart 18 increased in 
ampl1t11de and therefore the prean.re recorded at .... d1atal pointe 18 
greater :in magn.1t.ude than at points more prox1mal to the heart. 
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Thus if the mechanical effects of the pulse wave were the sole factors 
operant in medial damage it would be expected that the lesions would occur 
at maxima of the reflected ventricular waves. Such maxima would place medial 
lesions in the more peripheral arteries. Roszkowski (1956) in discussing 
localization of epinephrine induced lesions stated "In general .. only the 
thoraciC aorta was involved." Ie further states "Apparently' large trunks 
are the vessels primarily' affected.. small arteries and arterioles did not 
appear to be altered." This apparent lack of correlation between pulse 
wave maxima and localization of arterial lesions does not however cam-
pletely' rule out the importance of hemodynamic factors. It is entirely 
possible that mechanical effects of the arterial pulse wave might exert 
their damaging effects not at their maxima, but rather at sites in the 
arterial wall which by their structural or biochem1ca.l characteristics are 
particularly' susceptible to mechanical damage. Such an interpretation is 
consistent with Blumenthal'. (1959),hypothesis. 
A recent study by Wolinsky and Glagov (1964) examined the effects 
of intramural tension on the static mechanical properties of the rabbit 
aorta. In their experiments the rabbit aorta was removed under anesthesia 
and all branches tied. The aorta was washed in saline and attached to a 
cannula at the proximal end .. while the distal end was closed by a pinch 
clamp. After placing the preparation into a small airtight chamber .. 
various hydrostatic pressures were applied to the isolated arterial seg-
ment. Then .. the saline was flushed out by a fixative solu·tion and after 
a sui table period (usually 2 hours).. the segment was removed and. IrJtudied 
by both conventional histological techniques as well as via electron micro-
scopy. Several observations pertinent to the present discussion were made. 
Wolinsq and GlagOV' (1964) found that at ph3"Siological pressures the aortic 
media tunot.ions aa a two phase system in which the ·c1roumferentie.ll\r aligned 
collagen fibers bear the tangential etressmg foroea while the elestin net 
distributee the stressing forces uni£onUv throughout the wall"'. The intra .... 
lwdnal pres.urea employed 1n their stu.dies varied between; and 200 lIIIIHg. 
S1milarq Roach and Burtcn (1957) MacDcnald (1960) and Bergel (1961) 
have s~asted on the basis of their studies that the o~erent~ 
arranged m.edial collagen is the effective struct.ural compment of the aorta a 
and above physiological presnr8s. O'SUllivan's (l962) description of rupt 
of longituditla.l elastic fibers the t1r&t WV' after adm1n1stration of epin .... 
phrine 18 d1t:f'lcu1t to reconcUe with theae reports. Wollnsq and Glagov 
(l964) state that because of the two phase structural system present :In the 
rabbit aorta the ao:t'e extensible elast:in compane.nt distributes the stress. 
un1tormJ,. and that stresses around flaW8 are transferred to other parts of 
the arterial wall. Also mentiCl1ed is the observation that .. the aorta rarelT 
breaks despite nwaerous irregularities and f'law. of ccmpoe1tim and archi-
tecture wb1ch 1ncreue with age.1t In their ccncluding remarks Wollnaky and 
Olagov (l964) state tttocalaed1al detects and med.1al pressure and tena1cn 
gradicts IIUV' be relatlve~ insignificant factors in the development of' aorti 
diseas.·. Untortunat.eq theae studies were performed using stat:l.c rather 
pulsating pressures and theref O1"e do not c01"l"elate as cloaeq with in-vitro 
cmdltic:ruJ as might be de.ired. It should alao be emphasozecl that the studi 
ot Wolinsq and Glagov do not prectiLnde the occurrence of focal med1al l.eaiCl18 
in the .ona. 
Although the preceding discuu1cm raises a number of' questions 
ccncerning the s1gn1f1cance or pressor etrects. it does not obviate the 
participation of all cal'diovascular phenomena in the genesis of EPinephrine 
induced arteriopathJ. en. 'such aspect., tqdr08tatic tension, maY' be of 
signi.fieance. Tension in a. given Tessel is 811 expression of the stretching 
force exerted by the hydrostatic pressure m the vessel wa1.1, which in turn is 
opposed by the tensicn developed 1.."1 the wall of the vessel bT its smooth 
Illusele and elastic components. Hydr08tatic tension in a vessel III81' be calcu-
lated by applying the law of Laplace, represented by the ~ation r- P x R; 
~ll Which P is the excess ot the hydrostatic pressure maida the vessel over 
the local surrounding tiBsue pressure in dynes/em. 2 J T J the tension developed 
in the wall in dynes per square centimeterJ and R, the radius of the cylinder 
in centimeters (MacDmal<i, ).960). Using literature data Blumenthal (19,6) has 
calculated levels of hydrostat1e tension in various arteries. Thus, in an 
a.orta with a radius of 1.3 em. and a mean pressure of 100 mm..Hg., the tensim 
on the wall was oalculated to be 170,000 d:¥n •• /cm. 2• In arteries such 8.$ the 
hepatic or splenic having a smaJJer radius, eg. 0.15 ems., the tensiCll was 
calculated to be 20,000 dynes/em.2• In the rabbit aorta the bTdrostatic 
tension acting on the veasel wall should therefore be ccnsiderabll' higher than 
that £ound 1n vessels of smaller radius as the feaoral artery. Such a tansioa. 
gradient would. parallel the localliation or epinephrine induced lesions 
reported by Roazkowsld. (19S6). This Una of reascning suggests that protec-
tion against possible mec.hs.Idcal aspects of epinephrine induced arler:Lal 
damaae could be produced by reduction of arterial presffa:re changes via 
decrease in per1,pheral resietance, accompanied by no change or a decrease ill 
aortic radius. RegretablT such qualitative data CI'l these parameters was not 
obtained in the present study, due to t.be difficulties attendant in their 
deter'lldnatim. 
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Biochemical A!)?!Cts 
from the very outset of this examination of epinephrine induced 
medial aelerosis the uniqueness of the lletaboliSlll ot &rter1a1 tissue bee .. 
evident. cae of the strildng points noted was that aortic tiHl1e exhibits a 
rather low respiratol7' rate. Kirk et ale (19,3, 19,4) have reported that the 
respiratory rate of human aortic tissue is onJ¥ about ~ that of liver tissue 
Brills et al. (19~) have reported that in the rat aortic respiration proceeda1 
in Titro at a rate abou,t one-ta1th that of liver slices from the same animal. 
RegrettabJ, these two studies did not otter compari.sons of aortic tisll\1e with 
intest1nal SIIlOOth muscle or skeletal muscle. 'ontaine et al. (l96O) have 
reported that in the ax: aorta sixty to n1nav percent of glucose is metab-
ol1aed T1a gl\rColy'sia. while most of the remainder varying tr_ 10 to 3~ is 
metabol.1sed via the Ireba cycle. To the cmtrary, the liver exhibits an 
aerobic clrcolTlis ot about 30 to 4O,C and oxidative metabol18m of about 60 to 
70%. 'fuus the etticiency of carbob1'drate m.etabo1ia1l11n aortic tissue is mq 
abo\tt 4~ of that observed in liver (Fmtaine_et al., 196O). 1irk (1963) 
has calculated d1ffusim eoefficiEllts for OJCRen in human aortic tia8\le and 
ltates "These enimated depths to wbleb OXTien can penetrate through d1ff'uaicm 
indicate a low margin of rese",e for the ax;rgen auppq of the normal aort1o 
wall." Lehn1nger (19,ge) has also indicated that "If the diffusion of oqgc 
to the cella in the media is at all limited, then it can reasonabJ, 'be 
apected that the d1ftu1on ot glueOH, the aubstrate for alveoll'si. must alao 
be liIlited, &ince both are 'brought into the cella by ph;vsical d1ffu81m, so 
tar as is mO.h lt fontaine et al. (1960) has indicated that distances between 
adjacent capillaries "in parenchylllatous organs averages frcm ten to thirty' 
microrul, but it increase. to five hundred microns tor ar\erial walls, thus 
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illustrating the poor vascularization coming from the vasa vasorwn." This 
compares with mean capillary distances of 17 to 83 microns in skeletal 
muscle (Pearson 1962). A similar position is held by Kirk et a1. (1955) 
who state that the arterial wall fed either by diffus10n fram the lumen 
or by the vasa vasorum in the advent1 tia and media presents extended 
diffusion distances for the inward passage of substrate and oxygen and 
outward diffus10n of metabolites. Another peculiarity of arterial tissue 
is its low concentration of ATP which in the ox aorta 1s approximately 
1. 34 lM/IOO gma. (Kempf et ale 19(1). Th1s level is only about two to 
four percent of that reported in skeletal. muscle by Bendall and Davey (1957~. 
The rather low metabolic efflciency and extended dlffusion paths 
for metabolic substrates in the aorta suggested that this tlssue might be 
susceptible to blochemical defects. Therefore, several. exploratory studies 
were undertaken in an effort to survey blochemical aspects of arterial 
metabolism which might be profitably explored to gain insight into possible 
biochemical aspects of epinephrine artenopathy. In the course of such 
pl10t experiments it was found that lncreases in blood glucose and lactic 
acid following epinephrine levelled off approximately two to three hours 
atter administration of this drug. Subsequently tissue experiments were 
conducted ln which aortic levels of glycogen, phosphate, and lactic acid 
were determined at two, four and eight hours atter epinephrine administra-
tion in fasted rabbits. A significant deplet10n in aortlc glycogen vas 
observed four hours after eplnephrine administration. This decrease in 
glycogen of approximately 40;' was paralleled by a decrease of approximate~ 
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6f:II, in skeletal DlUSCle. At the peak depletion time aorta contained 40 mgs.~ 
and skeletal muscle 41 mgs.~ gll'cogen (Table 4).. The _ller percentage 
decrease in aortic glycogen is intel1:)Med u being in part a consequence of a 
lower level of epinephrine controlled glycol;rtic activit)" in tb18 tisaue. 
Such an interpretation 18 consistent with the report by ltla1ner et ale (1962) 
who reported a ve1'7 low level of cyclase in dog aorta as compared with dog 
skel.etal !IWIcle. 
Since Fouta (l962) hu reported oumulative ettects on drug JI8't,ab-
011_ tollowing repeated epinephrine administration, 8Ubacute exper1Mnts were 
conducted in which epinephrine, th7rox1ne, and epinephrine plus thJrox1ne were 
adm:1nistered daily for a period of two weeks, in accordance with the proced-
ures used by Gester et ale (19S4, 19$9). Drug adm1nistratim was tel"ldnated 
twenty-four hours prerl.oua to autopsy with the expectation that arrr altera-
tion. in levels of tissue constituents would be of a sub-acute rather than 
acute nature. Aortic glycogen levels which on an acute basis were decreased 
b)" epinephrine, were not sign1.ticantly changed b)" subacute epinephrine 
adm1nistraticm. '!bTrox1ne adm1n1stration for a two week period did :esult in 
a slight decrease in aortic cll'oogen, an effect which appeared to be 
potentiated by cCllcomitant administration of epinephrine (Fig. lO, Table $). 
COIIIParative detel'llinationl on skeletal mu8cle indicated no stat1atically 
s1gnitioant changes of cqcogen level in any of the groups. Aortic glucose 
l ... e18 were 81gn1.t1cantly elevated in an:!.mala treated with epinephrine or 
epinephrine plus thJrox1ne (rig. n, Table 6). Skeletal l'IlWJC18 glucose was 
a1gnif'icantly emated cnq in an:i:llall recei'rlng epinephrine alene. Subacute 
epinephrine alone or in cexnb1nation with tb1radne did not produce an)" 
significant changes in lactic dehydrogenase or lactic acid levels in the 
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aorla (Tables 1, 8). 
Tbe lower levela of aortic phosphate (Table 9) observed in both 
thyroxine treated groups are difficult to reconcile w1 th Hooh' s (l962) 
statement that tissue levels of inorganic phosphate usu.al.l1' rise in animala 
treated with th1'rox1ne and are contrary to our expectations. Thus in the 
biochemical studies a few changes occurred which appear to be related to 
effects of epinephrine on oarbolV'drate metabo1:1.sm. 'lbe acute depletiCll of 
aortic gqcogen following epinephrine appears to be a consequence of stimula-
ticm of glTcoqs1s. The subacute increase in aortic glucose could. be 
interpreted as a decrease in ut1l1zaticn or a consequence of increased uptake 
f'rora the blood. 
Metabolic Studies U.illl RadioisotopicaJJ, Labelled Subetrates 
The •• studi.s disclosed several points which ma.Y be important 
(Fig. l6-2S, Tabl •• 10-14). Th. first of these, st1m.ul.atim of c14o.z produc-
tion by epinephrine, was a rather consistent fincHn'b when aortic tissue was 
1ncubated in a medium cmta1n1ng glucose-6-C14 (Fig. 16-19, Tables 10, ll, 13) 
Pretreatment of animals for two weeks with thyroxine prior to aperiments more 
than doubled c14~ production f'rcm glucose-6-C14 (Figs. 16, 11). \l;llen aortic 
tissue was :incubated in a mediUDl cCIIUJist1ng of Krebs-Ringer bicarbCllate 
+ o. ~ml. of non labelled glucose and glUC08e-6-C14 as a labelled IUbstrate 
an accentuatim of the effects of epinephrine were noted. Under the.e cClldi-
tions epinephrine addition increased the fonaation of labelled carbon dioxide 
nearll' tonrfold, (rigs. 19, 22, Table 11) while norepinephrine appeared 
impotent (Table 13). m, phctolam1ne and phenQ1q'bensam1ne appeared to 
1nh1bit this st1Dmlating effect of ep1nephr1ne (Table U). Phctolam1ne, 
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which according to O'Sullivan (1962) is mO.r8 effective in preventing 
epinephrine artenapathy' than phsOJq'benzandne was the more effective of the 
two drugs in this regard, even lowering ol402 production to aub-control levels 
(see Fig. 19). A'tP which according to Davia at al. (1955) is also an 
excellent propb;ylactic agent against epinephrine art.eriopatbT did not inhibit 
c~ productim to as great an extent &8 either phenOJq'benzamine or phentol~ 
audne suggesting that its role as a preventive agent may be unrelated to its 
ettects on carbohydrate metabolism. 
Under similar ccnditions aortic tis8Uef'rom animals pretreated with 
thyroxine for two weeks exhibited a rate of c1402 production trice that 
obsel"'V8d in centrol tissues f'rcm normal animals (Figs. 20, 23, Table 12). 
However, the rate of formation of' labelled carbal dioxide b.r normal aortic 
tissue under the inf'luence of epinephrine was nearq double that found in the 
case of the thyroid controls. Aortic tissue from thyroxine pretreated animals 
vas also susceptible to the metabolic stimulating effect of epinephrine in 
that addition ot epinephrine nearl¥ doubled c1402 production in these tisn .. 
tig •• 20, 23, Table 12). Aa in the case of' aortic tissue from normal animals 
both phentolaine and phenox;rbensamine 1nh1b1ted the epinephrine st1mulating 
effect, the latter drug being less effective in this regard. A'tP did not 
appear to affect the epinephrine induced stimlllatim of metabolism in tissue 
from thyroxine pretreated animals. 
From the above cl1acusaion it is apparent that there JI87 be a 
correlation betweSl atim"] .. tim or 1nh1bitim of OJd.dation via the Krebs c,ycle 
and production tR prevention of epinephrine arteriopatby. Thus, epinephrine 
which when adminiatered alme to rabbits on a subacute basis produced medial 
arterial sclerosis (OesteI' 1959) also causes a substantial rise 1n rate of' 
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axidation via the Krebs cycle. 
Thy'rt'Xldne administered alone on a subacute basis does not produce 
medial sclerosis, but when administered concurrently with epinephrine appears 
to greatq potentiate the sclerogenic effect of' the latter drug (Michulicich 
and Oester 19,1). In the studies where unlabelled glucose was present in the 
medium the rate of oxidation of labelled glucose although higber in thyroxine 
pretreated animals did not reach the levels produced in nonal animals by 
epinephrine (Figs. 20" 2), Tables 11. 12). There alao appears to be a 
consistmt relationship between the potency of the two adrenergic blocldng 
agents in inhibiting oxidation by arterial tissue under the influence of 
epinephrine and the ability to protect aga1nst epinephrine sclerosis in the 
intact animal. PhCltoludne which is the more potent of the two drugs in 
inhibiting epinephrine sclerosis (O'SulliVWt 1962) i8 also more potent in 
1nh1biting oxidation by aortic tissue treated with epinephrine. It mq be 
recalled that phentolamine and phenoxybenzudne showed 8:5 mi lar potency- in 
inhibiting the pressor effect of epinephrine in the intact animal. Thus in 
this case there appears to be a better correlatim between metabolic 1nhibi-
tion and ability to protect aga1nat epinephrine sclerosi8 than is the case in 
regard to inhibition of pressor efrects. 
Hexose Monq>hosphate Shunt 
In aortic tissue from normal animals the Tield of clla.02 obtained 
from. glucose labelled in the number one position was near:t,' twice that obt 
from glucotSe labelled :in the nUllber six poe! t10n (Figa. 19, 20, 22, 2). 
Similar observation. have been made b7 W'inegrad et al. (l9S8) and J¥nn et al. 
(l96O) in adipose tissue. Sbarra et &1. (1960) have reported that production 
of labelled carbon dioxide by guinea pig aorta is poeater when the glucose 
substrate is labelled :in the number me positim than when the label is :In the 
number six position, paralleling our results. '!'he yield of c14~ !'rom. glucos. 
6-014 is believed to reflect oxidation via the Krebs cy'o18, while the increase 
in yield. of labelled CO2 from glucose-l-C14 i8 belitNed t.o be a cQlsequance of 
the participation of the hexose monophoBphate shunt (ph08pbogluconate 
ox1dative patbwq). 
It the huoae monopboaphate shunt is not preBalt or operant in a 
partioular tissue the yield of radioactive carbm dioxide ill the same regard-
lesa whether the label is :In the one ar six position. 'i'be dUferential 
observed in our experiments thus, suggests that, since the Tield ot radio-
active carbUldioxide is greater when glucose-l-C14 i8 used as a substrate as 
compared with glucose l.a\>ttUed in the six position the hexose monophosphate 
shunt is operant in rabbit aorta. 
In aortic tiuue from normal aniuls the ratio ot c1402 formed fr_ 
gluco.e-l-C14 as ccmpared with that tormed frOll glucose-6-C14 vas about two 
(Fig. 19, Table 14). This same ratio in aortic tissue from animals pretreated 
far two weeks with thyroxine vas approx1mateljr six, thus indicating a rather 
significant st1mulatiCll of the hexose llOllophosphate shunt by tlly'roxine in this 
tillsue (r1g. 2), Table 14). 
When epinephrine was added to aortic tusue from nOl'Jlal an1.mals 
(Fig. 19), yield of labelled. carbcn dioxide trOll glucosa-6-C14 vas increased 
almost tour fold. en the other hmd, :In similar exper.lm.ants where glucose-l ... 
c14 vaa used as a substrate the yield ot labelled carbal dioxide was increued 
by (I'lli' a factor ot less than fift,. percent. The added increment ill inter-
preted as stimulation ot oxidative phosphorylation in the Krebs cycle with no 
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Sl':Psrent stimulation ot the hexose nom.ophosphate shunt, but rather in inhibi ... 
tim of catabolism via tM.s route. 
Aortic samplee from. tIvroxine nretreated. anir.Lals challenged with 
epinephrine exhibited a. level of' c~ from glucose-l..c14 whioh was not 
significantly d:if:t'arent fran that observed in controls (Figs. 20, 23, Table 
This observation indicates that an inhibition of the hexose monophosphate 
sm.mt occurred in thyroxine pretreated animals. 
It is felt that the data obtained on the participation of the hexose 
manophoapbate shunt in nomal and thyrox:1ne pretreated aorta may as~ist in the 
resolution of certain inconsistencies in interpretation of the pharmacological 
role of thyroxine in experimental arteriosclerosis. It 1. a wen know faci; 
that conec:xn1tant adm:1n1stratim of th;vTax1ne to aninlals on a high cholest,erol 
diet provides protectian againut atheroma formation (Constant1!lides 1960). 
C(xl'\"erse~ rabbits treated with epinephrine and tl'1¥roJdne appear to be more 
prone to dev9lopment of arterial lesions when cholesterol is administered 
intravenousl;r !>ester et &1. (195SD or when ted in the diet (Constantinides 
at al.. (l96O~. 
Koritz and Peren (1957) have reported that TPHH and hexose monopho.-
phate shunt enzymes are required for steroid biosynthesis in oell tree systems. 
Thus" it is possible that the 'lftH generated in the hexose monophosphate shunt 
is utilized in the "detoxit1catim" of' chole.terol making it more vater 
soluble and thus inoreasing its potential for removal. and excretion via the 
kidney. This supposition is further strengthened b.T the report by' 'l'alalq 
and WiU:Sa.u-Ashman (19,8) that estradiol appears to :f.'unctiQ.Yl as an. essential 
co-factor :in a DPB-'fPNB Unked transhydrogenation reaction. Also, the lower 
incidence or CO!'Cll&ry' arteriosclerosis in premenopausal females haa been 
ascribed to andogonOU::i estrof;en. Thus, if cholest.erol atherosclerosis 18 
looked upcn as a. ctXls€lquence of irJ.su!ticient he:;s;ose monophosphate shunt 
act.ivity, drugs which sti.1lUlate shunt activity should proYide protection 
U6ainst athez·oscleroais. Our findings which show a rather striking stinrJ.l.a-
tion of the hexose rtlOnophosphata shunt activity by thyrcotil'lO lI'lltiiost that this 
~ be the cue. The potentiation of cholesterol athercxna formation by 
epinephrine-tl:lyrOJdne regimen may be a consequence ot the :inhibition of this 
shunt by epinephrine. OUr studies indicate that suoh '::<-1 inhibition does OCCU1'\ 
Prom. our discuasiorL of the stimtllatmg effect of epinephr'lne on 
c14~ productic:n trom glucose-6-C14 by a~erial t1s~ it is apparent that 
this increase in metabolism 1& Primaril3' if' no1i 8ols~ due to effeeta en the 
Krebs cycle. Since it is generall¥ believed that the mitochcmdria are the 
site of oxidative phoepho1"1'latiOD via the Krebs cycle we feel that it might be 
rea.a<nable to postulate a hlPot.hetical site of aetim for epinephrine on the 
mitoobcndrion in arterial tissue. 
If the increase in oxidative phoaphorylaticn is due to a 8welllng 
of arterial mitochondria _ m1.gbt expect some parall.eliam between Haulta 
which we have obtained and data reported on the swell1ng of Ddtochondr1a by' 
Lehninger (19$9a. c) and others. Chappel (19S8) haa reported. that the 
swelling of hepatic mitochondria ill pot.entiated by addition of substrate and 
does not occur in the presence ot metabolic inhibitors or ab.coe of amostr .. 
It we CCIIIIJ)U'e the results obtained in aortic .~lea incubated in a medium 
free of non-labelled glucose with studies in which O.5JWml.. of non-labelled 
glucose was added (Figs. 1.8, 19) we will note that in the latter case (0£ 
added substrate) the effect of epinephrine 18 vaatq enhanced. Results 
observed with ImP alene were s:l.milar to those which D.B alone was used a. a 
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aed1um. Thus, it epinephrine acted in a unner similar to that of t~e 
we would expect that the extent of swelling and subsequent increase in metab-
011_ would be greater in a medium containing glucose than in its absence. 
Such an etfect was noted in the mB and DB + nCll-labelled glucose experiments 
(Figs. 18, 19, Tables 10, 11, 13). Lehninger (19,9b) has reported that 
thyrClDdne induced swelling ot mitochondria can be prevented or reversed by 
addition of A'fP. Inhibition of epinephrine induced increase in oxidaticm by 
ill could pos.lbll" be uplai."led by aasUDdng that &8 in the case of thyroxine, 
A'l'P :1nh1bits the mitochondrial swel.l1ng produced by epinephrine and tbus 
inhibits the increase in oxidative phosphor.rlation. The effects of phentol ... 
udne and phenox;ybenumine are less clear. It might be proposed that these 
drugs act by' interfering with the postulated ... ellin, effect ot epinephrine of 
arterial mitochOl'ldria or that the,y :IIlV cause a cmtractiOll of IlitochClldria 
.ither directq ,. ind1rectlsY. In any event .... do teel that our tindings 
suggest that nudies of pouible eftects of epinephrine on arterial Dd.\ochon-
dria might be protitab:q a:plored. 
According to Zamecn.1k (19S4) addition of ATP to t18sue slices 
inereaaes the incorpOl"at1cm ot 1Botopicall3 labelled amino ac1ds into protein. 
Converaeq Boob (1962) indicated that thyroxine in h1gb doses is bel1wed to 
inhibit protein synthesis. 
'!hus, 1t ... as telt that investigaticm of the ettects ot epinephrin., 
thyroxin. and UP on the incorporatim ot 014 un1f~ labelled 37sme into 
aortic protein Blight prari.de SCIIIe suggestim u to a possible mechanism by 
which epinephrine causes medial arteriopathT. 
The nudie. which were performed indicated that epinephrine signiti-
cantll' decreased the incorporatiCll ot unit~ labelled 37sine 0.lJ.a. into 
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arterial protein (Figs_ 24, 2S, fable 1$). Incorporation of labelled qSine 
into protein we alao 81@Pir1oantl;r inhibited in aortic tissue obtained trCilll 
.Smale pretreated for two weeks with t~oxine. Noteworthy was the observa-
tim that protein synthesis s1gnificantl¥ depressed by t.by-rax1ne pretreatmEnt 
of animals vu 1'urther depressed by addlt1Cl1 of epinephrine to the ineubatiCll 
f'lulal (Fig. 2$, Table 1$). Neither phentolamine or phEmO'll'benzam1ne appeared 
to s1gnit1cantl¥ 1nh:1l>1t the depressim of protein synthesis caused by' epin .... 
phrine, which was nullified by ATP. 
Data &CC\1ll1Ulated on both protein synthesiS and carboh7drate 
metabolism suggest that drugs involved in :lnductiCll, potctiation or preven-
tion of epinephrine induced medial arteriopathy exert an effect an the meta.boo-
ol.iam of arterial tissue which 1n general is consistent with their role in 
art.eriopatby. Epinephrine, sine qua non, appears to affect not onlT oxidative 
phosphorylatim but also appears to exert an inhibitol'7 effect on protein 
synthesis, '!he 1nh:1l>itioo ot protein synthesis observed ma;r be a cCIlsequenoe 
of the effect of epinephrine on A.!P availability. Since At}' has been found. to 
be essmtial for amino acid activation, reduction in tiasue A'1'P should result 
in reduced protein ayntheaie • 
.An mer .... in oxidative phoaphor,ylation follow1ng addition of 
epintphr1ne to arterial tissue should reeult in a higher tiasue ATP level, but 
~ if the rate of destructim of AT' .. ere unaltered. Two :recent reporla 
auggest that this 1Iq not be the ca... Stamm. and Honig (1962) have reported 
that epinephrine interferes with the inhibition of cardiac aden081nephoapha-
tue activiV by' the so called relaxing substance (BS). Acoording to Parker 
and Gergel3 (1960) RS 1s an important pbTeio1og1cal modifier of 1I\fotibrillar 
ATP-ase activity' and is thought to terainate oantraction in heart muscle by 
8 
inhibiting ATP hydrolysis. In Stamm and Honig'. (1962) experiments RS obtaiDad 
from cardiac muac1e inhibited cardiac AfP-ase by approximately t0X't7 percent. 
Epinephrine addition to the incubation nd.xture containing both ATP-ase and IS 
decreased this inhibition bT appraximately 16%. This ef1"ect a.ppeared to be 
doe. dependent since lower cQlcentrations of epinephrine caused less inhibi-
tion of the IS activity. If'nn et 1.1. (1960) have indicated that in adipose 
tissue "epinephrine and AC'1'H promote the synthesis 01" ADP from ATPU. 'ftle,r 
also 81J.ggest that the stimulation 01" resplratiCll b,y epinephrine 1n adipose 
tissue may be mediated via this effect, since it is generally accepted that 
tis8Ue ADP level is one o! the fa,otors cClltrollL"lg l'flte 01" carhobJdrate 
metaboJJ.am. 
InUl1lUCh as epinephrine has been reported to have an -uncoupling-
etfeet on ;lTP it is entirel¥ possible that such an effect Obtalx18 in arterial 
tissue. If epinephrine increased the level 01" avaUable ATP we m1ght e:xpect 
that protein .,-nthesis wwld be stimulated when epinephrine was added to 
arterial tissue. Such an effect was not ob.erved. If the tissue ATP leTel 
was a l1m1t1ng factor in depres.ion ot protein eynthes1s by epinephrine we 
would expect A'tP to reverse this inhibition. 'ftd8 effect was observed. 
Addition of A'tP to arterial tissue where protein eyntbesis i8 depressed by 
ep:1nephr1ne resulted in a l'flte ot protem synthesis simUar to that :in 
controls. Thus, there 18 reason to believe that inhibition of protein 
synthesis by ep:1nephrine ..,. be 1.1nked to UP availabU1ty. 
A possible axplanatial of protective action provided by phentol-
amine lUI' lie 1n substrate ccn8ervatim. As 1nd1cated previouaq ep1nephr1ne 
produced deplet10n 01" aortic gl1'cogen. This effect appeared to be accentuated 
by concomitant administration of epinephrine and tbyrox1De. Breit.tar (19$6) 
has reported that adrenergic bloc1d.na agent. can prevent the thy'roxine induced 
inorease 1n raeta'bo1.ism. The r.ulta obtained in the present 1nvest1gat1cm are 
cons1atent with hi. f1ndings since additioll or phetltoludne to arterial tiawe 
frOia tiW-l'OlUn8 and epinephrine pretreated an:iJlal8 rfisl.\l.ted in c14~ productic 
which vu 01' the .sue urder of mat;nltude ae that observed in aorUc sample. 
i'rom 1'1armal ard.mala not pretreated with tb,yrox1ne and epinephrine. 'lb.G leu 
potent aot,iv11iy of phflll0X7ber:lzaino in pnrnIlt,lng epmephr1ne acle:roau 
p.araUels It.s lager potency 1n regard to 1nh1b1\1ng ad.d&t1ve pboaph..,-latiCil 
by .ortio tuaue. 
Failure or norepinephrine to c1gnit1cant.l;v increase Kreba cycle 
a.d.daUOIlb,r aortic tiafte b consistent with ita l.oIHr potency in 1nduc1nl 
medial arteriopatb7 aa conpared "ith epinepbrit1e reported tv Fl"ledman et 81. 
(l9S'., b). Both druca produce effects Ql aystol1c pruaure which are 
Alt.bcach the abon 41acuee1ol1 has PNMnt.«i ft1denoe suggesting the 
e.x1.atance or a aetabol1o oOllPClDent 1n the IGA1.al. of epinephrine arteriopa\llT 
it should. be ~b.t that Sl1 rive da'- doe. not neouaar1J, Nflect 
obaDgea wh10h T.ake place in the .t~onrsal1n\Kt an1mal. In viVo :\.n4,uba'ttion. of 
t1asUfI au.ttera fn:a • n\ll'Ilber of ahortcom:J.op ;in that unavo1dabl.e t:t'1lUM 
WNall;y OCCUft in prepantlon of the u.ue IUlPle, \he 1neubatiGn ... lUll on 
pee8ll' approx1mata that present nomal.ll' and iD .... CU .. I'f*)t:tan.. found 
to 0CCt.ll' in isolated t11.8 proceed Gftly to a lJ.m:1ted ext.alt in tbttl intaot 
animal. Dwp!.te th .. ., di8liift:ltq.. in vitro incubat.lon hal 1n a !lUl\\ber of 
lnstance. f.efIl'l uaef.ul in ~din.S limpls aodela useful in the fJtuf!y of 'DOre 
oouplclot .,-at_. 
Ocnclusi0l8 
In general, a poor- correlation was obsM'Ted between the abilitT of 
drugs studied to modit)' .. on an acute basis .. the pressor response t.o epine-
phrine, and their rela:t.lve effectiveness in preventing Or augmeuting 
epinephrine arteriopa~ a.e reported by other inveetigatorlh For exa.~le 
thyrcDdne which signifieantlQ augments epinephr:ina arteriopatlv (Michulle1ch 
end Oeater, 1951) did not potentiate the net rise in STl1.\)l1c and diastolic 
bl..ood pressure fol.lurlrli; epinephrine. The net pressor rise foll.aw1ng 
norep:tnephrlne dld not signifieantl,- differ with that obserYed toll..ow:lni 
epinephrine, however norepin.ephrine administered on a subacute oo.sis ill 
reported to cause a lower incidence snd severity of medial !esiells than 
epinephrine triedlun et al. 39"a, 'b). Uthough phentolamine and phenOXT-
benzam1ne were found to be similar 1n their ability to reduce the pressor 
respcmse following epinephrine, phel'l:tola.n:dne is reported to be more active as 
a prCPhTlaet1c agent V$ epinephrine artariq>athy" (OtSulliT8Jl, 1962). 
m which 18 reported to be one or the II!.08t pot8'lt prophylactic 
a,gents w ep1nephl'1ne arter:Lopathy, wa. less etteetive in 1nhlb'.ting the net 
epmephrine pressor effect than phEl'lOll;1ben.ltmine whiclJ. is re1at1velT 1mpotct 
in this regard • 
. CD. the other hand t.he deereases in pre-infusion s.ratol1c and 
diastolic pressures prmuced by' ATP and phentolurlne appu:r to pa.rallel their 
prophylactic value in ep1."lepbrine arter1opat.bT as reported b7 Davis at 81. 
(19S5) and O'SU.ll1van (1962). The possibility that protec~ion against 
mechanical aspects of epinephrme induced arterial dmu.ge could be a. em .... 
Clllence of reduct1m of intravascular wall temd.CI:! 111 raised. A.lthouch the 
present report, questt.ona the importance of increuea in .78tolic and 
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diastolic preuure8 in the genesis of epinephrine arteriopathy, it 18 entirelT 
possible that acute oardiovascular relationships noted in the present study 
'IIa7 not retlect subacute cardicmulc'Ular .ffects. 
Data in th1a report suggest that study or the relatlvel;y unexplored 
metabolic eftects of epmepbr1ne <Xl arterial tune ..., asa1at in the ident1-
tioaU_ of a specific leal. or lesions which precipitate medial arterlopatl'r. 
Tbe rather significant effects of ep1nephrine 111 potentiating Krebs cycle 
oxidatiGD, 1nb1b1t.1an ot protein synt.beata and 1nh1blt1on o.t ox1dat.1. via the 
huon JD"lophospbate shunt auggut f'urther areas tor profitable 'lnveat1gation. 
It 111 the op1niGll of the author that one or more of the ... ftects ... be 
ocmtrl.but.ory tutors m productim ot fI'1ed~ 81 azoter1opatJl)". 
Correlation between .trects ot epinephrine, norepinephrine, 
t.bTradne, phentola1ll:1.ne and pbenoxy'benMJline en KNb8 C7C18 addatiem and the 
abil1ty ot" the .. several drugs to llOdity incidence and e.,edty of subacutel;r 
induced arter1alles1ms appeare to be cons1ltent with a bioohaioal bypoth-
.. is of med.1al aclerog.es1a. !hu, t.bTroxine wh1ch aupente epinephrine 
arter1opathy, induced an increaae in ox1dat1m via the Krebs cycle. Phentol-
amine which is reported to p1"OV1de protection against. subacute medial 
arteriopatbT (O'SUllivan, 1.962) was quite effectiYe 1n 1nb.1bit1ng effeeta of 
epinephrine on Krebs cyole metabol1snt. Pbentolam1ne vu found to be more 
potent in th18 regard tbat phccq'benzam1ne wb1ch 18 infer1Ol" U a proph1'-
lacUo &i-t. Norepinephl"me reported by F1"1edJun e\ &1. (l9SSa, b) to be 
la. eftectiYe in inducing med.1al. arter10patny \ban epinephrine did not. 
produce any eignificant etrect en. Krebs cycle oxldati«t. Although A'tP vas not 
particulal"l¥ effectiYe 11'1 inhibiting etfeets ot epinephrine em carbohydrate 
meta'bol1a, it was the .. t potent of the three drugs studied in rev81"8ing 
1nhlblt,ion of protein syntbea18 CAUSed by ep1nephrine. 
It 18 the op1nion of th18 author that epinephrine arter10pathy is a 
rather ccaplex pbanomenon which is the resultant of .... raJ, vect,o:ral factors. 
Data 1n this report suggest that, greater weight be given to biochem1cal 
faetora than ha.B been heretofore aacr1bed. 1be biochemical effects observed 
follodng in-vitl"o incubatiGl of arteri.al tissue with epinephrine suggest that 
th1a drug .". exert a biochemical act,ion CIl the genesu of medial arter1opatlv. 
Such biochemical effects if' sufficiently intense could summate with oth..-
l.es1cm induCing tactol"8, thUB contributing to the genuis of Dl8d1al uteri-
opatl\Y'. It 1B possible that a b1oebem1cal les1(1'1 induoed by epinephr1ne 
m1ght exert a pe1'ld.u:l.ve action on the 1nduot1C1l or lee1on. by h81llOdynUl1c 
tacton. 
Chapter VI 
StImmal"Y 
1. Subacute adldnistratim of' thyroJdne increased mUng s,yetolic and 
diastol.1e pressure in the unanesthetized .rabbit but did not aign1ticantll' 
augDIa'lt the pressor etf'ect of ep1nephrme. 
2. A'tP did not slgnif'icant~ decrease the net increase 1n syatol1c pressure 
follow1ng ep:inephrine in normal rabbits or si~ficantl¥ alter the pressor 
response to epinephrine in rabbi 1;$ pretreated for two weeks with ~ax1n 
3. Phctol_ne and phanaxyben.sud.ne, at dOMe emplored, reduced pressOJ:" 
effects of epinephrine to a s1mUar extant. 
4. Ipra:d.u1d did not signit1cantl¥ alter the preuor reapalse to epinephrine 
in the rabbit. 
S. ATP and phentolam1ne reduced centrol systolic and d1utol1.o pnasu:ree to 
a greater extet tluan did phenCDifbenH1l1ne. 
6. Ability or drugs studied to modify the pressor reapmn toll.ou1ng 
epinephrine adJrdn181:.ration in the rabblt did not. appear to correlate well 
with their abUity to IIlOdif'y the incidence and sever1tT of epinephrine 
arteriopatb7 as reported in the literature. 
7. Epinephrine produced several Mtabol1c effects en rabbit aorUc tissue 
such as depletion of tiaeue sl¥cogen, et1JmlatiCll of' oxidation via the 
Krebs cycle, 1nh1biticn of oxidati<l1 'ria the hexose monophosphate shunt, 
and inhibittcm of protein synthesis. 
8. St:l..mnlat1m of Krebs c.rcle a:ddation tollOldng additJ.cm. of epinephrine to 
rabbit aorta auggeets a poes1ble b1ochem1oal mode of' actim of' thia drug 
an vaecular tissue. 
9. N orep1nephrine which is reported to possess lesser aelerogenic potency 
was leas effective than epinapbrine in st1mulat.1ng oxidation in arterial 
t.issue. Both drugs produced s1m:U.ar increases in systolic pressure. 
10. Augmentation of hmtoee monophosphate shunt activity by thyrax1ne Wi\}" 
explain l"8.Ported protective action against cholesterol atherosclerosis 
by tb1a d.rug. 
11. Inhibition of hexose monophosphate shunt activity may t!aPlain augmcta-
tim by epinephrine of' intimal leaiona following cboleaterol feeding 
reported by Cmstantinides (19S8). 
12. There appeared to be good correlatim between the ability of drugs 
studied to augment or :tnbibit Kreba CTCle cm1dation and the ability of a 
drug to intEnsity or amel10rate epinephrine arteriopath1'. 
13. AfP which although less potent in inhibiting effects of epinephrine <1'1 
car~te metabol.1sm, reversed epinephrine induced inhibitlen or 
protein ayntheai. in t.b1rox1ne pretreated an1mala. ATP may act at more 
than Q'le po1nt in 1nh1b1ting epinephrine aner1opatby. 
14. Correlation betvem augmentation or 1nh1biticn of biochemical effects of 
epinepbr1ne in rabblt aorta appears to be consistent with the role ot a 
given drug in increasing or decreasing medial arter10patbT toll.owing 
subacute adm1nistraticn ot ep1nephrine. 
35. Data preaented suggest that epinephrine produces medial arteriopatby in 
the rabbit by a mecbaniam which may include biochemical effects on aortic 
:metabol1lm. 
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APPENDIX 
Bray, G. A., AnaJ.. B1ochem. 1: 279-285 (1960). 
Scintillation fluid for radioisotope experiments, was prepared as 
follows: 
60 €JIlS. Naptha1ene 
4 £9ll8. PPO (2,5, dipheny1oxazole) scintillation grade 
0.2 mn. POPOP (1,4 .. bis-2(5 .. phenyloxazole)-benzene 
scintillation grade 
100 ml. absolute methanol (AR grade) 
20 ml. ethylene glycol (AR grade) 
Q.S. to 1 liter with p .. dioxane (scintillation grade) use 
purest quality avallable commercially. 
PPO and POPOP were obtained. fram Packard Instrument Canpany. 
It was found that only the purest grade of dioxane could be used. 
slnce analytical grade yellowed in the presence of HYam1ne-10X 
and caused considerable quenching. 
Buffer solutions used for incubation of aortic tissue in racUoisotope 
exper1ments were prepared as described by Long (1961). 
o.c;;, BaCl 
1.15~ XCl 
l.22J Cac~ 
2.11~~ 
3.82~ MgS04 
0.1 M l'fa2BP04 
1.~ NaRC03* 
, 
JCrebs-Ringer 
phosphate 
(KRP) 
100 mJ.s. 
4 m.l.8. 
1 ml. 
1 ml. 
21 mls. 
Krebs-Ringer 
bicarbonate 
(KW) 
100 mls. 
4 mls. 
3 mlS. 
1 ml. 
1 ml. 
* 1aBC03 solution was saturated with CO2 before addition to prevent 
precipitation of calcium. 
Prior to use buffers were gassed Wi th 1~ oxygen for the Krebs-Ringer 
Phosphate butfer or 5j CO2 95~ O2 for the Krebs-Ringer Bicarbonate 
buffer. 
Inoren1c and Labile PhQSPbate Determination 
Method used was that described by Fiske and SubbaRov (1929). 
~ principle of the method is based on the formation of a ph08phanolyb-
date camplex With inorganic phosphate and molybdate ion in the presence 
of sulfurtc aCid. 
Reagents: 5 J Sultur1c acid (reagent grade). 
2.51r ammonium molybdate. 
Bed.ucing reagent prepared in powdered fom and stored in dessieator. 
Contained 0.2 f!Iil .. of 1 amino .. 2-napthol-4 .. sulfonic aCid, 1.2 €Pl- sodium 
bisulfite and 1.2 sm. sodium sulfite. The mixture was ground to a fine 
powder with a mortar and pestle. For use, 0.25 gm. of powdered reagent 
was dissolved in 10 m.ls. at distilled vater prior to use. 
Standard solution concentrate containing 1.3613 p •. ~ in 1 L. of 
distilled water wu prepared. For use as a standard this solution was 
diluted 1:10 so that it contained 1 mieromole of phosphate per ml. 
Tissues were deproteinized u deSCribed in lactic acid pro-
cedu.re. A 0.5 ml. aliquot of this supernatant vas used. To the unknOWn 
sample 1 ml. ot sulfuric acid was added, followed by 1 IDl. of the ammonium 
molybdate solution. After mixing, 0.1 ml. of reducing solution was added 
and volume adjusted to 10 mla. by addition of' distilled vater. After 10 
minutes optical density 'Was measured. at 660 mu. in a Bectlmlan DU spectra .. 
photaueter. In procedure for analysis of lab11e phosphate sult'u.r1c acid 
vas added to unknown and volume adjusted to 5 mls. 
Samples were then heated in a boiling vater bath tor seven minutes, cooled 
• 
and then addition of molybdate and reducing solution vas carried. out. As 
a final step the volume was adjusted to 10 mls. Samples were read as 
described above after 10 minutes. In all analysis standards containing 
1.0, 0.5 and 0.25 uM phosphate were also processed and calibration curve 
used to ex .. rapolate results. Labile phOsphate was calculated by sub-
tract1ng values for inorganic phosphate from. labile phosphate values. 
Lactic Acid Determination. Method of Barker & Summerson (l~l) 
The method is based on the quantitative conversion ~ lactic 
acid into acotaldeb¥de \lben beated in concentrated sulf'uric acid. !l'he 
aoetald~ formed is determined via formation of a purple colored 
complex wi tb lVdroxy diphenyl. 
Reagents: 4~ Solution 01' ~. 5B:zO. Concentrated Sulfuric 
Acid (Reagent grade). 1.5; Solution of p-bydroxydiphenyl in 0.5j HaOH. 
Lactate standard. 
Suhsequent to l~val of tissues fx-om. the a.n1mal the weighed. 
sample W8 hanogenized in a Pot-ter Ilvehem type glus bcmogenizer, immersed 
in an ice bath. In all cases the tissue sample wu 1mmernd in 2.5 cc. of 
ice cold distilled water for hClnogenization and the resultant supernatant 
freed of cellular debris was processed as suggested by Barker and Summerson. 
Alec. aliquot was deproteinized by add1 t10n of 1 co. of l~ 1'CA and the 
supernatant used for dete:t:mination of tissue lactic acid. The size of 
aliquot used vas usually 0.2 mls. This 'Was adjusted up to a volume of 1 cc. 
by addition of distilled water. To the test tube contain1ng this aliquot in 
a volUl'!1e of lee., 1 drop of 4~ ~ wu added, and the tube ehilled in an 
ice ba·th. Af'ter equilibration, eold concentrated sulfuric acid was added 
trom a pipetting 8yTi~~ set at 6 mla. During addition of aCid, tUbe waa 
swirled to m1nim:1ze heating. 
1'hi8 swirling was continued until tube and contents were approx1mately 
at room t.en;>erat.ure. When additlon of' reagents to all tubes i:n the s6r1es 
waa cCBpleted,t1'.l.e tubes were withdrawn tram the ice 'bath ln wbioh they 
'Were stored and heated in a bolling vater batb for 5 minutes. 
On ~val. :fran the boU1:ng vater bath, they were aga1n cooled 
to bela., 200(:. Two Uraj:l" of the p·b;ydroJQd1plleuyl reagent were a4ded fram 
a 1 ml. pipet'te (0.1 &l.) and the reagent dispersed by stlrr1:ng 111 th a th1:n 
glasa l'od. 'rlw tUbes ",ere then "aged II tor 30 m1:nutea in a water- bath at 
25°C room ~r&ture. DuriJlg this period the prec1pitated p-h,ydroxy-
diphelQ"l reagent was resuspeDiad at least three time.. At the end of the 
30 minute pel~iod the excess p .. by~pheDyl reagent was destroyed by 
heat1.'a.8 the tubes in boiling water for 90 secontla and then recooling. 
Color developmen;t was _asured in a Beclulan DU speotrophotameter at 560 :m.u. 
Prior to reading of Nolilples the instrument 'VU adJusted to Zftl'O optical 
dens1t~ by use of a sulturic acid blank, in acco~c. with Barker and 
Summerson t 8 recamnendat1on. Along with each seri.. of Ul'lknotms a calibra-
tion curve was established 'WIling knu.m uauntll of a(:-1010 acid. 'l'bese were 
prepared to contain 2, It and 6 meg. of lactic ac14 per tube. 1w::! samples 
''''bich gave Nad1ugs in a range beyond an O.D. of 0.600 were rerun a't 
higher dilution. 
Lactic De&grggepue 'LOR) As"!l - for use in arterial tissue. 
Kittinaer et 81. (1960). 
The prinCiple of the method is based on the oxidation of l'P0 
and reduction of pyruvic to lactic acid. D.PD has a strong absorption 
band at 340 mu. wbile II'1I absorbs very little at this wave lenth. 'l'hus, 
clJange in optical deMity is proportional to oxidation of DPII. 
-~ -4 lleagents: 4 x 10 - M • Pyruvate, 1.2 x 10 M !PD, 0 .. 1 M phosphate 
butter pi T.8. 
Pieces of aortic or skeletal muscle tiseue were ha.nogen1zed 
as previously described 1n the lactiC I1ci4 analytical method. Totul 
volume of saline uae4 was 2.5 mls. Homogenate was cleared by centri-
:f'Ugation f'or 10 m1mltes at 3000 rpm. The f'011ow1ug reagents veloe a4ded 
to a Beekman JlJ cuvette centrirtlge tube 1) 0.1 ml. of' .&Pyruvate, 
2) 0.1 ti. of J.l'1I and 3) 2.75 ml. p!lospbate butter. This solutior! 
was It,irre4 with a tine glUe rod and 0.05 al. of' tissue haaogeMte 
supernatent were added and apin the contents were stirred. The re-
sut tant solution was rapidly placed in a :Beckman DU spectrophotameter 
and change in optical Cf.er18ity recOl'ded at 30 second. intervals, for a 
period of three minutes. Rate of cbo.nge in optical density wss can," 
pared with standard C"I1rV"e obtained by adding varytllg amounts of DPJH to 
the butter system described above. Activity 'Wt.UJ expressed as rate of 
sul;,.trate reacting per unit 01' time, one unit being equivalent to 
oxidation of 1 JD1eraaole 01' !)PH per minute. All data. W*l'8 correct .. i
tor dilution and tissue weight. 
Glucose Determination (Glucose Ox1dase Procedure) 
This procedure is based on the ox1dat1on of glucose via 
glucose oxidase forming ~~ and glucon1c ac1d. The peroxide tom d 
ox1dizes a chrauogen which in reduced torm does not absorb at 400 mu. 
Real:;ent: Glucostat reagent, Worthington Biochemical Corp., Freebold, 
N. J. was dissolved in distilled water and chromogen added. The final 
volume was adjusted to 98 ml. in accordance with the manufacturers 
instructions. 
Deproteini~ed solution was obtained by treating tissue 
homogenate or blood wi tb 1 ml. each of the Somogyi reagents (2. ~ 
ZnS04°7J:il:2O and 1.8~ Ba(OHr.2). Thus, blood was processed by adding 
0.2 ti. of whole blood to l.B BIl. of H2O, and 1 rol. of each of the 
Somogyi reagents was added. Tissue extract was prepared by 
homogenization in distilled water in a volume of 5 mls. A 2 rol. 
aliquot of the f'iltrate was then processed as described for blood 
with add1t~ion of 1 ml. of each of the Sau.ogyi reagents. 
Color DevelOj?tnent 
Two mls. of the tissue extract were placed in a test tube, 
8.0 mls. of glucose oxidose reagent were then added and the resultant 
solution was incubated at 3rfC tor 30 minutes. At th1s point one drop 
of 4nCl was added to each tube to stop the react1on. Samples were then 
read. 1n a Beckman 00. spectrophotometer at 400 mu. Instrument was set 
at lO~ transmission by use of a reagent blank. A calibration curve 
waa establiahed USing known amounts of glucose tor each series of 
determinations. 
Protein Detem1nations 
.F ....... _~
Protein va. detel'ldned by the method described by Gornal eft &1. (19ft-8). 
The method i. baaed on tbe toxmatj,on of a vIolet color when 
proteiJW or polypetides containing aa14e or pepti4e linkage. react Vi th 
copper aultate in a strongly al kaUne solut1on. 
ieagenta& Biuret reagent (00rDa.ll et al, 19lt8) conta1n1~ the 
following. 1.5 19B. cupr1c .ulfate (~. 5¥). 6.0 sm. pote.aaium 
tartrate (1aICC4,06* ~ ~O) 41&8olved. in approx1mateq 500 ml .. of 
cUst111ed water to Which is added. 300 ml. of l~ IaOB. Q.S. to 1 lIter. 
ODe ml. of tis.ue Supenw.tant, obtained by haaoprd.z1ng 40 to 
100 mg. of tis.ue in 5 ml. of distilled water and. centrtfu3\tIon at 3000 
rpm. tor 15 minutea vas placed in a 12 ml. centrtt'ub ... tube. 'l'o thU waa 
added .. ml. of bIuret reagent and the resultant solution WIllS allowecl to 
stard for 30 minute. at rocm ~rature. Unknowns aDd stan4ar48 were 
react in a Beckman 00 apectrophotam.eter at 540 lIN .. adjusted to &ere O.D. 
with 41et1Ue4 vater. Bea&ent blank and proteIn standarda ",.re uae4. as 
OODtrol& 11'1 each n1"1.. of ana.lysis. Protein staD4al'd was obtaine4 tr= 
Da4e reagents (Lab-'rrol) a:od adJuste4 to contain .083*, o.16151t and 
0.2515~ of protein in each reapect1ve sample. 
Procedure follow eel vas essentially that described by Seitter 
et ale (1950). 1'bis method is a modification of the procedure of Good 
et al. (1933). 
Principle of the method involvu the separat.ion of glycogen 
:fran tissue and other conta.m1nanta I bydrolya1s of glycogen to glucose 
aDd determination of glucose present by the development ot color vi th 
anthrone reagent. 
Reagents: ~ lOB, 95j ethanol, 60j ethanol, O.2~ anthrone in 
95; sulfuric acid (reagent grade). 
Aortic ancl skeletal muscle tissuea were rapidly excised fran 
rabbits, veighed on a Mettler 'balance, and placed in a test tube con-
taiD1ng 1 1Dl. of :JJ1, KOB. The test tube vas then placed in a boiling 
vater bath and heated for twenty minutes. At the end of this t1me, the 
tube vas allowed to cool to l"OCD temperature and 1.25 mla. of 95~ ethanol 
added. Contents were D'l1xeIi with the aid of a thin glass rod which vas 
rinsed wi th 6~ ethanol which was ad4ed to the contents of the tube. 
i'he sample was then heated to boiling in a vater bath, cool.eel to room 
temperature aDd centri1'uged tor 15 minutes at 3000 rpm. The su;pernatant 
was decanted and the precipitate redissolved in 1 ml. ot distilled water aDd 
rep:recipitated as described above. rus procedure vas repeated twice. 
In preparation tor analysis the sample of glycogen vas dissolved in 2., mls. 
ot distilled water and cooled in an ice bath. 
Cold anthrone rea.gent was then added fran a pipetting syringe and the 
contents of the tube swirled in the ice bath. The tube containing 
glycogen and anthrone reagent vere "capped II with glass marbles and 
heated in a boiling water bath for 10 minutes. Samples were then 
cooled and stirred with a thin glass rod and read at 620 mu. in a 
Beckman DU spectl'Ophotometer. A reagent blank was used to adjust the 
lnstrument iD zero O.D. Standards containing 10, 20 and 50 micrograms 
of glucose were also run with each set of unknowns. Tissue samples 
used in the ana.l.ysi& varied from about 40 to 100 mg. depending on 
ava1la.bi1ity. 
)!'. 
Incubation Flasks 
Problems aasooiated with clew 116 of Warburg f'laaks in :rad10-
iSotope exrAriments are particularly disconcerting since not only mu.o;t 
the ve8sel be chemically clean but I!ll.Ult alBO be free of radioisotopes 
vb1cb when present in onl7 trace quantities are 11kel7 to alter results 
significantly. Dur1.ng the coune of pilot cxper..m.ente pl"elim1ntIU"Y to 
the ratio1sotope ~&l"1!:lentG described in this l'ePOl."'C the d.esil'abiU ty 
of bav1118 a tfdisposable Vali:n.t.r" fl.a.&k" becamo eVident. As a. I.'Etsult a 
disposable metabol.1ea fluk. W&II developed, aa1 ia pictured em tbe sub ... 
• equent page.. The aomponenta are ratber 1ne.x;ponsiw, total c.'Out be1ug 
in the noigbborhood of twlw cents, aDd arc rea4ily available u stock 
1teaa from DlO8t scientific 8'\loWly house8. 'fbeH are: 
1. Serum vial stoppers (rubber). 
2. Disposable plastic "D1spo" beakers (2 ml.). 
3. Copper Vire 22 e;auge. 
4. l'11ter paper. 
,. Disposable glas. count1ng vials. 
As&embly procedure 1$ ae follove: 
1. Fold filter paper :111 ehapo ot fluted stan approximately 
3/1.6" hlp aDd v:1th a ra41,. ot 7/16". A three la;ye:rec1 
to14 vas f'0un.4 to have Iat1stactor;y absol.'1)anoy. 
2. Pierce d1apOH.ble plutlc beakel"8 W1th • red hot 23 gause 
DM4le 80 as to produce two holes at appoai te ends of tbe 
the top of the b-.lter. 
3. Plaee f:1lter paper into bottan of' beakers and "tie" 
the beaker vi th eopper wire (a8 per photOgl"e.ph). 
4. Thread $1I11Q1ng end or copper w1re through hole 
prev:1oua17 punched through bott(lJl of l.ower margin Of 
l'Ubber serum vi.$l8topper.SUpott any rema1n1ng 
~ with v1~ cutter. 
Prior to \l.8e 0.2 ml~ of 4. B KOIl 18 applied onto the 
til tel" paper in the beaker taldns care pot to touch sides. A 
'.l'he counting vtala were pretille4. With previousl¥ gus. 
butter and. ra410acti va substrate prior to use. After tissue samples vere 
cleaDed am weighed the plaat10 cap on the counting vial contain1ng 
butter vas 1W1O'V'e4 and tissue sa.mplea placed in the medium. bs. glass 
vials were \hen placed in a _tabol1c abaker and SU .... via a manito14 to 
vhich 18 gauge 1l8e4le. wen attached ~or eutry of ox,.Pfl UJ4 a eec0a4 
nee4le ~ ext t of air l'Ilixture. After appropriate peeing the serum 
vial stoppers (With attache4 beaker coata1aSag KOa) were rap14ly attlxed. 
and a441 tlOD of 4Nga 1fU pertozme4 by iDJeotlOD throu&b the rubber 
stopper. When it vaa desired. to te:na1Jate the 1DcubatiOl1 0.5 ml. of 
4 • ~ vas a44e4 via a 23 sause ~c ..u. and syr1Dge. i'.be 
vial va then sba1um on aD lbel"bacll sbaker for twenty m1mttes at low 
speed. At tld.a tt. the viall were ~ from the IJhak1ng apparatwa, 
the GaPs lemoved aDd the plutte beakers vuhe4 vith 1 JIl. of 41still.ecl 
vater wbich vu al.l.cM!Id to flow Into the vial. ftssue aa.mples vere 
then ~ aD4 the vial contaSning me41_ .... nd1oact1ve substrate 
vas capped With a plat1e som cap aDd atored 1a a freezer tor 
ad4it1C1lal aualya1 •• 
'to each beaker (bans:1ns traa the .. nil v1al cap) 0.1 JIl. of 
1; 'fr1 ton )200 vas a44ed to .. sure wettins aa4 l'elease of cl402 trapped 
by the KOBO' '1'he S8rua vial stopper vas then placed atop .. MeODd. vial 
CODta1n1q 0., al. of JfJam1ne 10 X. Acid (0.4 Btl. or 4 I' ~so..) was 
acI4e4 to the 'beaker by 1nJectton throus,b the rubber "1'\111 vial cap, 
to etteat release of the c1~ which YU tbAn bOWl4 by the II1a1ne. 
to eftect releaae of the cl~ which was then bound by the lJ1am1ne. After 
.baking tor an additional. 30 minutes the .arum vial cap vas removed and 
10 mla. of Bray's solution added. The vial vas then capped witb a plastic 
screw cap and counted in a Packard llquid Scintillation Counter. 
During the course of development of this procedure yield and 
linear! ty of Cl~ trapping was determined by use of radioacti ve 1Ia2C1~. 
Canpa:rison of triplicate samples containing 0.0125, 0.025 and 0.05 uC per 
vial disclosed tbat the average variation between triplicate samples 
averaged 2.2j,. Data comparing yield and reproducibility for this pro-
ce4w:e aD1 for an alternate method using conventional Wa,n,urg flasks is 
tabulated below: 
"Disposable War'burg Conventional War'burg 
Flask" nash. 
Precision* ~ Yie14 Pnc1aica* j Yielc1 
0.0125 C l.~ l.22 3.8 110 
0.025 C 4.2j 111 0.8 16 
0.050 C 0.4j 105 11.1 90 
Average 1.9j 114 5.2 92 
* Percentage variation between triplicate samples. 
j yield was calculated va ~cl4~ counted in Bray·s .olution. 
'l'be difficult solubilit7 of this salt in the scintillation med.ium is in 
our o.pin1on responsible tor the yield in excess of looj ob •• rvecl. 
In ~'\I1ID8.ry I the "disposable Warburg flask It desoribed 
apr-ea1"8" fran this author'. experience to bave the following 
aci'VlUltage8 over and. abOve the conventional. War'burg flask when 
used tor radioisotope experiments: 
1. Greater acevacy. 2. Allows pretlUing of v1alJJ which 
can be ccmven1ently 8tOred. 3. Although aaaewbat more expensive 
this prooedure allowed HOIlCIYIY of tiM ~ spent cleaning 
ordinary V!U'bUrg flasks. 4. Greater 81l11pllc1ty of bandllng -
elJm1lJ1!1t1on Of volUlll8triC transfer'S • _ s- 1'eaOftl of KOB trca center 
well at Warburg fla&k 8l'l4 the lSeftral r1D81DC8 De_seary to ettect 
c<Dp1ete :removal ot trapped Cl~. 5. Allove4 a greater number 
of experiments to be conducted nch working 4aT. 
It should be eeg;>hU1ze4 that the proce4un described. 
above 1e ~ su1tabl.e tor uae when DJfiI.UQD.e'tl'ic _thoda aft aploye4. 
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